Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,46289,0.0215141887368629,0.00914001136734752,0.00359976645686181,0.0394286110168641,0.0185844122635915
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,40383,0.0247858105331276,0.0103016520421694,0.00459457253047554,0.0449770485357796,0.0161325776804494
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1070.Time spent watching television (TV),48675,0.0119530849265385,0.00914422658514446,-0.00596959918034466,0.0298757690334216,0.19116018340551
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1080.Time spent using computer,40386,-0.0251452892850379,0.00947770179867108,-0.0437215848104332,-0.00656899375964255,0.00797874835264501
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1090.Time spent driving,35024,-0.00420129804258025,0.0103602950433661,-0.0245074763275777,0.0161048802424172,0.685098422852552
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1160.Sleep duration,51285,-0.00860916363157862,0.00834426982439945,-0.0249639324874015,0.00774560522424431,0.302196178900241
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,17163,0.0305582300064983,0.0247161585188646,-0.0178854406904763,0.0790019007034729,0.21633930134303
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,17163,0.0308550989326088,0.0240727301142609,-0.0163274520913426,0.0780376499565602,0.199949479164398
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,17163,-0.0282152700754907,0.0275123249756304,-0.0821394270277264,0.0257088868767449,0.305118122198694
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,17163,0.0123214084328198,0.0282448439795149,-0.0430384857670294,0.0676813026326691,0.662671242027725
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,17163,0.00522960503513496,0.0286668209932134,-0.0509573641115634,0.0614165741818333,0.855249715834921
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,17163,-0.110007885896121,0.0608871714583883,-0.229346741954562,0.00933097016232026,0.0708188170654837
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,17163,0.0344472197898496,0.0630946087490992,-0.0892182133583848,0.158112652938084,0.585099585087938
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,17163,-0.0141275208528375,0.0435394276520493,-0.0994647990508541,0.0712097573451791,0.745581272793024
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,17163,-0.0212224228471127,0.0318000258921967,-0.0835504735958182,0.0411056279015928,0.504544008965387
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,17163,-0.00820259980633128,0.0217892667784794,-0.0509095626921509,0.0345043630794884,0.706586003086289
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,17163,0.0363520238773802,0.0314152765464007,-0.0252219181535652,0.0979259659083255,0.247229323340186
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,17163,-0.000137318455408689,0.0176491461667328,-0.0347296449422049,0.0344550080313876,0.993792245145454
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,17163,0.00493451603990107,0.0227875747220877,-0.0397291304153908,0.0495981624951929,0.828566189039619
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,17163,0.0587665348525959,0.0338014256204109,-0.0074842593634095,0.125017329068601,0.0821263414538248
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,17163,-0.0115463533072525,0.0318410797320032,-0.0739548695819788,0.0508621629674738,0.716889928967498
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,17163,0.0209109056606826,0.0426409053692835,-0.062665268863113,0.104487080184478,0.623860375147743
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,17163,0.0219333797137603,0.0402467561900238,-0.0569502624186864,0.100817021846207,0.585779443525432
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,17163,0.0049261474496972,0.0247987226425865,-0.0436793489297724,0.0535316438291668,0.84254264117622
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,17163,-0.0107899130185595,0.0234988856935627,-0.0568477289779424,0.0352679029408234,0.64612006082702
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,17163,0.0368290846567847,0.029340131132917,-0.0206775723637326,0.094335741677302,0.209406545759069
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,17176,-0.000595864952959104,0.0148282490127051,-0.029659233017861,0.0284675031119428,0.967946546402105
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,17175,-0.00761379030383144,0.0146950968336314,-0.0364161800977489,0.0211885994900861,0.604382806527645
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,17176,0.0023596994504602,0.0159558959266927,-0.0289138565658576,0.033633255466778,0.882432208055581
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120098.Mobility problems today,17184,-0.00909973226731814,0.0174218980122712,-0.0432466523713698,0.0250471878367335,0.601457222952305
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120099.Self-care problems today,17184,-0.0446810658335404,0.0269443960392458,-0.0974920820704622,0.00812995040338128,0.0972813842065978
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120100.Problems doing usual activities,17184,0.0101033547423666,0.0166131496666812,-0.0224584186043285,0.0426651280890617,0.543093333093415
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120101.Pain or discomfort today,17184,-0.00315909650674806,0.0148270149264056,-0.032220045762503,0.0259018527490069,0.831279920987827
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120102.Anxiety or depression today,17184,0.0105186334931645,0.0180080090927302,-0.0247770643285867,0.0458143313149157,0.559154904952741
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,17129,0.00744855079524229,0.00766504320096066,-0.0075749338786406,0.0224720354691252,0.33118574316764
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,17145,-0.0113788014041823,0.0181646443044008,-0.0469815042408079,0.0242239014324434,0.531044054911348
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",17120,0.00718916944491522,0.0186874303336551,-0.0294381940090487,0.0438165328988791,0.700459918643799
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",17155,0.00538671553727205,0.0147515479089175,-0.0235263183642062,0.0342997494387503,0.714994441627083
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,17154,-0.00482443907346159,0.0150696005752033,-0.0343608562008601,0.0247119780539369,0.748863232720652
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,17163,-0.026965705154712,0.0195326858390997,-0.0652497693993474,0.0113183590899235,0.167437633718246
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,17116,0.00291541244929592,0.0196289690630237,-0.0355573669142305,0.0413881918128224,0.881929412164099
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,17161,-0.01091261152221,0.0196469274339504,-0.0494205892927528,0.0275953662483329,0.578603695836659
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,17143,-0.0271816471250703,0.0286859640722197,-0.0834061367066208,0.0290428424564802,0.343367310219996
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,17070,-0.0339813976614927,0.0390152371884477,-0.11045126255085,0.0424884672278649,0.383778643853278
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11966,-0.00928282418746079,0.0201542102820214,-0.0487850763402228,0.0302194279653012,0.645101294246051
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46388,0.031593612990056,0.0203677831118705,-0.00832724190921025,0.0715144678893223,0.120871080687682
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43294,0.042417978102022,0.0124197823746282,0.0180752046477506,0.0667607515562933,0.000637571558052531
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,49799,-0.00547859470860108,0.00872505363345669,-0.0225796998301762,0.011622510412974,0.530062304832347
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,48449,-0.0300435601121004,0.00923161236305083,-0.04813752034368,-0.0119495998805208,0.001137013590453
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,49707,-0.0220027769612826,0.00914226028053274,-0.0399216071111268,-0.00408394681143848,0.0161005339561546
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,46948,-0.0191280340236569,0.00940631427703914,-0.0375644100066536,-0.000691658040660167,0.0420044936087696
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X134.Number of self-reported cancers,51727,-0.00771936625810978,0.0163320258924563,-0.0397301370073241,0.0242914044911045,0.636463403835249
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51728,0.0317571280669168,0.00866832022692286,0.014767220422148,0.0487470357116856,0.000248957835533187
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",51728,-0.00517117815415001,0.00856722051783336,-0.0219629303691034,0.0116205740608034,0.546111961503649
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,51728,0.0230716144885833,0.00849127943769012,0.00642870679071069,0.039714522186456,0.00658795763450233
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1438.Bread intake,50233,-0.00337820514532048,0.00461395905518042,-0.0124215648934741,0.00566515460283314,0.46406786665246
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1458.Cereal intake,49104,-0.0125226432048239,0.00866730899802867,-0.0295105688409601,0.00446528243131233,0.148516720762089
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1488.Tea intake,49923,-0.000849595996852216,0.00441114435055094,-0.00949543892393205,0.00779624693022762,0.847271324950612
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1498.Coffee intake,47654,0.012238693085551,0.00872077860098576,-0.0048540329723811,0.0293314191434831,0.160505737708797
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1528.Water intake,47820,-0.00397911191132131,0.00885007982670294,-0.0213252683716591,0.0133670445490164,0.652991472159916
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,35220,-0.024870248613348,0.010073044603475,-0.0446134160361589,-0.00512708119053703,0.0135542032302283
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,35210,-0.00103774747554445,0.0103028486514939,-0.0212313308324725,0.0191558358813836,0.91976987478568
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,35310,0.0102888001239884,0.0114400667528721,-0.012133730711641,0.0327113309596178,0.368464202280044
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,35168,5.60806324440363e-05,0.0111096660308633,-0.0217188647880481,0.0218310260529361,0.995972393552883
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,35285,0.0327498994553736,0.0183792358853958,-0.0032734028800022,0.0687732017907495,0.0747746827142945
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,38806,-0.0240358851945011,0.0102917863701201,-0.0442077864799364,-0.00386398390906577,0.0195253360904805
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1807.Father's age at death,38110,0.00142032200933278,0.00508660652290353,-0.00854942677555814,0.0113900707942237,0.780071517085416
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1845.Mother's age,19673,0.0196518245102179,0.011695618323368,-0.00327158740358332,0.0425752364240191,0.0929202188611018
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1873.Number of full brothers,50798,0.0063377226474987,0.00838388408155563,-0.0100946901523503,0.0227701354473477,0.449688010331844
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1883.Number of full sisters,50808,0.0190830232932986,0.00840225829750326,0.00261459703019222,0.035551449556405,0.0231403769412951
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20015.Sitting height,51321,-0.0304794515969856,0.00581055428899277,-0.0418681380034114,-0.0190907651905598,1.56448633539061e-07
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20016.Fluid intelligence score,16582,-0.00258108767795452,0.0143883575024431,-0.030782268382743,0.025620093026834,0.857635848526538
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20018.Prospective memory result,17272,-0.00666721866964725,0.0191421250203966,-0.0441857837096245,0.03085134637033,0.727618494224492
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),16362,-0.0031209892850848,0.00771380367167592,-0.0182400444815696,0.0119980659114,0.68577834633991
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),16340,0.000887342044064589,0.00771503036868411,-0.0142341174785563,0.0160088015666854,0.908434870437623
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,51102,0.000751832452929274,0.00466795616573518,-0.00839736163191168,0.00990102653777023,0.872044852094753
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,44995,0.00428536594898464,0.00995553348489276,-0.0152274796814052,0.0237982115793745,0.666869913717311
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44120,-0.0371371897415364,0.0219192647432811,-0.0800989486383674,0.00582456915529456,0.0902207273537256
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44049,0.0224824891683898,0.0294145033474586,-0.0351699373926291,0.0801349157294087,0.444672645101463
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44089,0.0355159741787351,0.0247710883350804,-0.0130353589580224,0.0840673073154926,0.151645799465196
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44114,0.0215907197981828,0.017701828902251,-0.0131048648502292,0.0562863044465949,0.222589448662841
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,44455,-0.00587616482602307,0.0128081754069494,-0.0309801886236438,0.0192278589715977,0.646392713511428
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44335,-0.00820283198075042,0.0161509371852805,-0.0398586688639002,0.0234530049023993,0.611535946925819
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44136,-0.0475697560855341,0.0201715788325786,-0.0871060505973882,-0.00803346157367998,0.0183653402003364
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44415,0.00982857097126591,0.0148186281514699,-0.0192159402056151,0.038873082148147,0.507168890692169
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44559,0.0076828873252694,0.0111453822370441,-0.0141620618593369,0.0295278365098757,0.490616900019838
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44283,-0.0145231354102314,0.0154712095402562,-0.0448467061091335,0.0158004352886708,0.347879590881321
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47192,0.00155250695933081,0.0113855366707369,-0.0207631449153134,0.023868158833975,0.891538998779144
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46903,0.0522440962287079,0.0163326533871231,0.0202320955899467,0.0842560968674691,0.00138115904409567
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46754,-0.00419567184135845,0.0355407532435723,-0.0738555481987601,0.0654642045160432,0.906026632314813
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46825,0.0264686722446978,0.0183101720354811,-0.00941926494484521,0.0623566094342408,0.14830397567959
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,47065,0.00642362695489299,0.0129655088508589,-0.0189887703927905,0.0318360243025765,0.620292137599693
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46853,-0.0211643306997157,0.0229103820477742,-0.0660686795133531,0.0237400181139217,0.355601583709953
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46816,-0.0086048914069949,0.0205318302274925,-0.0488472786528801,0.0316374958388903,0.675144925727348
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46853,0.00956690011209729,0.0167237584575318,-0.0232116664646651,0.0423454666888597,0.567287845639981
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46907,0.0215777982290762,0.0191937197925509,-0.0160418925643236,0.059197489022476,0.260929117254182
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47266,0.00529322098800619,0.00984798237108922,-0.0140088244593287,0.0245952664353411,0.590929692148432
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46971,0.013527109908418,0.0151947050658245,-0.0162545120205981,0.0433087318374342,0.373335385160033
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,40457,-0.010020452455657,0.0159053136642136,-0.0411948672375156,0.0211539623262017,0.528693830609393
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,40166,0.0483918543044869,0.063190355838296,-0.0754612431385733,0.172244951747547,0.443793413749328
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,40155,0.00485884887843391,0.0643441178577586,-0.121255622122773,0.130973319879641,0.939806541296706
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,40276,-0.0267051217782584,0.0187960344852625,-0.0635453493693729,0.010135105812856,0.155387049137861
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,40187,0.018937704612152,0.037177017277654,-0.0539292492520498,0.0918046584763537,0.610479725998361
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,40234,0.00661934839934162,0.0268785231227706,-0.0460625569212888,0.059301253719972,0.805475222245538
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,40188,0.0674961660830018,0.0318799676962899,0.00501142939827363,0.12998090276773,0.0342492755540182
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,40189,-0.00888980105509615,0.0309328252857265,-0.06951813861512,0.0517385365049277,0.773814793692306
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,40213,-0.0113211843859524,0.0234885962212387,-0.0573588329795804,0.0347164642076755,0.629818217863769
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,40234,-0.00404251986214747,0.0288687593020573,-0.0606252880941798,0.0525402483698848,0.888636235965293
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,40598,-0.0087864997296864,0.011887273616337,-0.0320855560177069,0.0145125565583341,0.459819098306421
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,40375,0.0141093429304899,0.016853089800179,-0.0189227130778609,0.0471413989388408,0.402487243774797
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20127.Neuroticism score,41124,0.00799499287792934,0.00876738487546762,-0.0091890814779872,0.0251790672338459,0.361825832923558
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16582,0.0153647378707741,0.014617158143532,-0.0132848920905487,0.0440143678320968,0.293207806060365
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,15764,0.0179057764997949,0.00859011155801524,0.00106915784608505,0.0347423951535048,0.0371340721152055
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15764,0.018313971541247,0.00847323454878485,0.00170643182562873,0.0349215112568654,0.030680179944673
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20191.Fluid intelligence score,12774,0.0113406162811162,0.0158855033880244,-0.0197949703594116,0.0424762029216441,0.475303823056418
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12775,0.0234379408582396,0.0162497630087077,-0.00841159463882745,0.0552874763553067,0.149226575309082
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,11479,0.00720116965568986,0.0171724888862363,-0.0264569085613332,0.0408592478727129,0.674973054247919
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20255.Spirometry QC measure,38477,0.0313137357188469,0.011159551614452,0.00944101455452094,0.0531864568831729,0.00501854146549543
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20261.avMSE,11311,-0.0220227693989013,0.00907757741389753,-0.0398148211301404,-0.0042307176676621,0.015279196298029
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20262.Myopia diagnosis,11311,0.0269881248623489,0.022041915767798,-0.0162140300425351,0.0701902797672329,0.220826848962166
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,29510,0.0798334821991418,0.00585775755522382,0.0683522773909031,0.0913146870073804,3.6298859506569e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,29571,0.0940557801098849,0.00587008345420593,0.0825504165396413,0.105561143680129,1.54584933318655e-57
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,16150,0.019607502012891,0.0311784413509583,-0.0415022430349873,0.0807172470607693,0.529436442537573
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,16147,0.0528968978436622,0.0611216029894985,-0.0669014440157548,0.172695239703079,0.386811839214705
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),16146,-0.0756623508428037,0.0753230750905009,-0.223295578020185,0.0719708763345781,0.31515067888349
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),16146,0.00267874291239575,0.0295326357755724,-0.0552052232077262,0.0605627090325177,0.927728522349667
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),16146,0.0342517126682024,0.0513326418322706,-0.0663602653230481,0.134863690659453,0.504621910120829
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,16156,0.0321391278481354,0.0662955781064155,-0.0978002052404389,0.16207846093671,0.627835163892357
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,16156,0.0119704244012274,0.042785069277311,-0.0718883113823022,0.095829160184757,0.779649563939868
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,16156,-0.0461373801208481,0.0479307110638449,-0.140081573805984,0.0478068135642879,0.335770282668633
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,16156,-0.0184342970374854,0.0746274782882461,-0.164704154482448,0.127835560407477,0.804897781355801
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,16156,0.0494314147496707,0.0866361238641453,-0.120375388024054,0.219238217523396,0.568303471586255
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,16156,-0.031926182482737,0.0499108778393161,-0.129751503047797,0.0658991380823226,0.522400263458444
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,16156,0.0851057012566324,0.0860064311774046,-0.0834669038510806,0.253678306364345,0.322420110781495
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,16156,0.0292218684065494,0.0637028245164424,-0.0956356676456778,0.154079404458777,0.646440199995753
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),16158,0.108999846209351,0.0856369993263249,-0.0588486724702456,0.276848364888948,0.203102901323325
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),16158,-0.00240865388567156,0.0396491903738173,-0.0801210670183535,0.0753037592470104,0.951559754487541
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),16158,-0.0199145643747607,0.0594545512529506,-0.136445484830544,0.0966163560810224,0.737663825904303
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,16160,0.0662523837471776,0.0991919593981766,-0.128163856673248,0.260668624167604,0.50419362639174
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,18722,-0.00546102955869217,0.0131410418932868,-0.0312174716695343,0.02029541255215,0.677729073924133
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,18722,-0.0146966023799653,0.0130871299004537,-0.0403473769848546,0.0109541722249239,0.261459847013349
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,18722,0.0280704547523672,0.0131232261423214,0.00234893151341715,0.0537919779913172,0.0324493593747843
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20603.Liking for apples,18722,-0.00380883981367028,0.0134227521991166,-0.0301174341239389,0.0224997544965983,0.77659747200071
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,18722,-0.00844408042606914,0.0133018084236149,-0.0345156249363544,0.0176274640842161,0.525562097224114
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,18722,-0.0323770851504578,0.0131418768915941,-0.0581351638579822,-0.00661900644293333,0.0137616760983058
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20606.Liking for avocados,18722,0.00749275277042529,0.0132595685405304,-0.0184960015690143,0.0334815071098648,0.572024295270629
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20607.Liking for bacon,18722,0.00678145850425849,0.0132828768871486,-0.0192529801945529,0.0328158972030698,0.609678247938893
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,18722,-0.00295451867060557,0.0133595697957034,-0.0291392754701843,0.0232302381289731,0.824975151287226
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20609.Liking for bananas,18722,0.0149757319340259,0.0136151154428464,-0.011709894333953,0.0416613582020048,0.271374926186035
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18722,-0.0254487536693239,0.0132353093513048,-0.0513899599978813,0.00049245265923354,0.0545212842264408
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,18722,-0.00239149997127413,0.0132475494661216,-0.0283566969248725,0.0235736969823242,0.856743209392759
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,18722,0.00349738003425552,0.01336199043674,-0.0226921212217548,0.0296868812902658,0.793524052261634
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,18722,-0.00782642653827672,0.0132530281266972,-0.0338023616666032,0.0181495085900498,0.55483665788248
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,18722,-0.00197949323899709,0.013163894766181,-0.0277807269807118,0.0238217405027176,0.880472030279931
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,18722,0.0192625082780668,0.0132286934349737,-0.00666573085448174,0.0451907474106153,0.145377425861138
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,18722,-0.0192592535372826,0.0131507328703061,-0.0450346899630826,0.00651618288851745,0.14307408553404
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,18722,-0.0109993014897845,0.013432186920441,-0.0373263878538488,0.0153277848742798,0.412867345389294
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20618.Liking for black olives,18722,-0.0307405170989572,0.0131942179163453,-0.0566011842149941,-0.0048798499829204,0.0198247943431431
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,18722,-0.00338669157798675,0.0133104151915585,-0.0294751053534414,0.0227017221974679,0.799159057093716
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,18722,0.0131075670653503,0.0131628951893524,-0.0126917075057803,0.038906841636481,0.319361839085748
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,18722,-0.00562965535064149,0.0132279127592204,-0.0315563643587134,0.0202970536574304,0.670412189607523
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,18722,-0.00894158835450667,0.0131791417192313,-0.0347727061242,0.0168895294151867,0.497485209591485
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,18722,0.000212878263658827,0.0135557138242969,-0.0263563208319632,0.0267820773592808,0.987470742603608
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,18722,2.46845233769158e-05,0.0131922926157925,-0.0258322090035764,0.0258815780503303,0.998507073345488
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,18722,0.00530673917289922,0.0132889937739643,-0.0207396886240707,0.0313531669698692,0.689652114676934
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),18722,-0.0121012032814559,0.0131791557192093,-0.037932348491106,0.0137299419281942,0.358521940893726
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,18722,-0.0186949388425949,0.0131970468057162,-0.0445611505817987,0.00717127289660893,0.156616515384383
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,18722,0.0252981959823941,0.0133477953838536,-0.000863482969959035,0.0514598749347472,0.0580668913670296
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,18722,-0.0350464792090025,0.0131507785825052,-0.0608220052307126,-0.00927095318729229,0.00770604464004148
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,18722,-0.00047754339897878,0.0133506652768496,-0.0266448473416041,0.0256897605436465,0.971466727253769
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20631.Liking for cake,18722,0.0141154589409005,0.0132403838809332,-0.0118356934657286,0.0400666113475296,0.286396106728214
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,18722,0.0126129137779241,0.01307624717965,-0.0130165306941899,0.038242358250038,0.334774313559276
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20633.Liking for capers,18722,-0.0326908655981756,0.0131007042924066,-0.0583682460112925,-0.00701348518505863,0.0125917837705631
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,18722,0.000935636905020904,0.0134279396928918,-0.025383124893047,0.0272543987030888,0.944450405935985
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,18722,0.00945024368338476,0.0131139985422285,-0.0162531934593831,0.0351536808261526,0.471150755415931
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,18722,0.0301592696994743,0.0131586080612705,0.00436839789938406,0.0559501414995646,0.0219178417162446
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20637.Liking for cherries,18722,0.0057956356895341,0.013859191700393,-0.0213683800432361,0.0329596514223043,0.675820377368572
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20638.Liking for chicken,18722,-0.00552382106295787,0.0138181612322698,-0.0326074170782067,0.0215597749522909,0.689344634733922
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,18722,-0.0307003106599243,0.0131739703874944,-0.0565212926194133,-0.0048793287004352,0.0197968431063596
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,18722,-0.00396710256186569,0.0132707055643351,-0.0299776854679624,0.022043480344231,0.764991572280656
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,18722,-0.0229076572709142,0.021245600015622,-0.0645490333015334,0.018733718759705,0.280944742458739
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20642.Liking for cod,18722,0.0176461630067956,0.0135666530318424,-0.00894447693561544,0.0442368029492066,0.193376751846244
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,18722,-0.0122929544108318,0.0144225827644159,-0.0405612166290869,0.0159753078074233,0.394035934410621
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,18722,-0.00223105567646891,0.013412281589114,-0.0285191275911324,0.0240570162381946,0.867887857529419
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20645.Liking for coriander,18722,-0.0253426410407702,0.0131789146423372,-0.051173313739751,0.000488031658210691,0.0544991437016011
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,18722,0.0217128120944773,0.0131314759286594,-0.00402488072569505,0.0474505049146496,0.0982472230848721
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20647.Liking for cream,18722,0.0146047045288972,0.0131234579492642,-0.0111172730516606,0.040326682109455,0.265778510684621
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20648.Liking for croissant,18722,0.00509312025030678,0.0131717061800881,-0.020723423862666,0.0309096643632796,0.699003994004355
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,18722,-0.011432056606277,0.0132450277082133,-0.0373923109143749,0.014528197701821,0.388082218613002
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20650.Liking for curry,18722,-0.0242966078347889,0.0133433771582374,-0.0504496270649342,0.00185641139535642,0.0686419943244689
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,18722,0.0352720245074756,0.0133490133350125,0.00910795837085109,0.0614360906441002,0.00824149931712953
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,18722,-0.00462785778717011,0.0132559051595527,-0.0306094318998933,0.0213537163255531,0.727005635099789
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,18722,0.000767450451913012,0.0135794764187801,-0.0258483233288959,0.027383224232722,0.954931778138569
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,18722,-0.0130300208616344,0.0132480230152808,-0.0389961459715847,0.0129361042483159,0.325352224982657
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20655.Liking for eggs,18722,0.00111159023439781,0.0136237332142532,-0.0255909268655384,0.027814107334334,0.934971885005009
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,18722,0.0129962473345149,0.0131379688114485,-0.0127541715359241,0.0387466662049539,0.322571821275153
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,18722,0.0148371101109583,0.013167233123331,-0.0109706668107705,0.0406448870326871,0.259832780207859
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,18722,-0.0123569659489452,0.0133702644787071,-0.0385626843272111,0.0138487524293206,0.355387599665067
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,18722,-0.00526454449736776,0.0131553472877035,-0.0310490251812667,0.0205199361865312,0.6890264096563
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,18722,-0.00858247825661437,0.0140699209807733,-0.0361595233789301,0.0189945668657013,0.541877390616268
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,18722,-0.0021524879152988,0.0131150889046679,-0.0278580621684479,0.0235530863378503,0.86963607906555
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,18722,0.0151615619030468,0.0132114710443784,-0.0107329213439349,0.0410560451500286,0.251145981976558
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20663.Liking for fruit,18722,0.0145615917355175,0.01459759255252,-0.0140496896674217,0.0431728731384566,0.318518391926304
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20664.Liking for garlic,18722,-0.0191675353297687,0.0133408585119002,-0.0453156180130931,0.00698054735355574,0.150804561417156
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,18722,-0.0251094402038563,0.0131096302177602,-0.0508043154306663,0.000585435022953582,0.0554639947565
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,18722,-0.0136418819949929,0.013216264028751,-0.0395457594913448,0.012261995501359,0.301989861867459
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,18722,-0.0107850922356501,0.0131259375008124,-0.0365119297372424,0.0149417452659422,0.411279413447207
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,18722,-0.00719345364148336,0.0132427661966616,-0.0331492753869402,0.0187623681039734,0.586999463037956
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,18722,0.000591474185374781,0.0131147512372544,-0.0251134382396438,0.0262963866103933,0.964028149588174
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,18722,0.00106895029048322,0.01311735042321,-0.0246410565390084,0.0267789571199748,0.935052094299284
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,18722,0.00785275899101611,0.0131307779336906,-0.0178835657590174,0.0335890837410496,0.549819035389517
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20672.Liking for green olives,18722,-0.0141186029433845,0.0132209569537049,-0.0400316785726461,0.0117944726858771,0.28558135329092
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20673.Liking for haddock,18722,-0.00809559339765157,0.0134747798092812,-0.0345061618238427,0.0183149750285396,0.547983171007801
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20674.Liking for ham,18722,0.0161039048820121,0.0132690544139926,-0.00990344176941342,0.0421112515334377,0.224899124069879
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,18722,0.0177425816766206,0.0134796908259918,-0.00867761234232334,0.0441627756955644,0.188107808518795
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20676.Liking for herring,18722,-0.000300224114102713,0.0130800269118465,-0.0259370768613218,0.0253366286331164,0.981688114871353
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20677.Liking for honey,18722,0.013206997400756,0.013133378753561,-0.0125344249562235,0.0389484197577354,0.314618408197328
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,18722,-0.0192950451249694,0.0131553650472874,-0.0450795606176528,0.00648947036771396,0.142473026649947
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,18722,0.0262494872349356,0.0132392122675221,0.000300631190592322,0.0521983432792789,0.0474147060997367
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20680.Liking for jam,18722,0.0175244734607827,0.0131548559901352,-0.00825904427988225,0.0433079912014476,0.182821342857968
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,18722,0.00639780162028973,0.0131989975800066,-0.0194722336365232,0.0322678368771027,0.627881541415162
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20682.Liking for lager,18722,-0.0274303369735981,0.0132097078559354,-0.0533213643712315,-0.00153930957596472,0.0378587081693245
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20683.Liking for lamb,18722,-0.00173559184659129,0.0133284330402182,-0.0278593206054189,0.0243881369122363,0.8963959509723
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20684.Liking for lemons,18722,-0.0164890777918983,0.0132276939166291,-0.0424153578684913,0.00943720228469465,0.212575499133566
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,18722,-0.0286705247892492,0.0132864552844826,-0.0547119771468351,-0.00262907243166333,0.0309501550968865
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20686.Liking for liver,18722,0.0361568500740253,0.0131955058375666,0.0102936586323948,0.0620200415156559,0.00614809586185803
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,18722,-0.000993758948085651,0.0131607409380785,-0.0267888111867195,0.0248012932905482,0.939810269088521
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,18722,-0.00487562448467667,0.0130631198980994,-0.0304793394849515,0.0207280905155982,0.708977157197599
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,18722,-0.00938931527046182,0.0131880875877239,-0.0352379669424007,0.0164593364014771,0.476501976529978
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20690.Liking for melon,18722,0.00272730223493127,0.0135907254937289,-0.0239105197327773,0.0293651242026398,0.840955846969502
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,18722,0.0292642760244694,0.0132478261840538,0.00329853670372389,0.0552300153452149,0.0271876231140803
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,18722,0.000884724922131389,0.0135887519439927,-0.0257492288880944,0.0275186787323572,0.948089382983956
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,18722,0.0193342338274974,0.0131504637942247,-0.00644067520918306,0.0451091428641779,0.1415157325999
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20695.Liking for oranges,18722,-0.00612280128773567,0.0134405887579575,-0.0324663552533324,0.0202207526778611,0.648722047575047
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20696.Liking for pasta,18722,0.00747163081525676,0.0133117089995942,-0.0186193188239478,0.0335625804544614,0.574611618474248
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20697.Liking for pears,18722,0.0068663067511837,0.0134378303208732,-0.0194718406777277,0.0332044541800951,0.609379211850905
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20698.Liking for pizza,18722,-0.0195528870497832,0.0131719565161197,-0.0453699218213778,0.00626414772181138,0.137710939048738
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,18722,0.00878013757982098,0.0131917874189191,-0.0170757657612605,0.0346360409209025,0.505690337477602
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20700.Liking for plums,18722,0.000813640588020427,0.0134554283258677,-0.0255589989306804,0.0271862801067212,0.951782497219015
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20701.Liking for pollock,18722,0.00977766963551367,0.0131334149190977,-0.0159638236059177,0.0355191628769451,0.456590662008479
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,18722,0.00853139482651905,0.0131458886455053,-0.0172345469186713,0.0342973365717094,0.516360453337963
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20703.Liking for porridge,18722,0.0213131846281095,0.0133853225888025,-0.00492204764594327,0.0475484169021623,0.111338654498607
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,18722,0.0106827171454587,0.0132155377204067,-0.0152197367865385,0.036585171077456,0.418902143876392
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,18722,0.010161092102286,0.0134068341117024,-0.0161163027566507,0.0364384869612228,0.448518055235763
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20706.Liking for prawns,18722,0.00386337189132906,0.0133527253791274,-0.0223079698517606,0.0300347136344188,0.772330468204497
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,18722,-0.00297635315793985,0.0132949881758576,-0.0290345299826208,0.0230818236667411,0.822860662370597
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20708.Liking for red meat,18722,-0.010192751250591,0.0132526209504998,-0.0361678883135706,0.0157823858123887,0.441836474578138
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20709.Liking for red wine,18722,-0.0202010271756132,0.0132198425677037,-0.0461119186083125,0.0057098642570861,0.126508649279993
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18722,0.0269977779630803,0.0136196489645538,0.000303265992554789,0.0536922899336058,0.0474640019135181
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,18722,0.0107168441887611,0.0138185012131652,-0.0163674181890427,0.0378011065665649,0.438028576362277
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,18722,-0.0195436584522311,0.0132198267195362,-0.045454518822522,0.00636720191805977,0.139328382087978
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,18722,-0.00606971773731792,0.0134863352243739,-0.0325029347770908,0.020363499302455,0.652669310113882
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20714.Liking for salami,18722,-0.0241688678226114,0.0131863376351852,-0.0500140895875744,0.00167635394235159,0.0668375127535932
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20715.Liking for salmon,18722,-0.02355253118973,0.0137711275609625,-0.0505439412092164,0.00343887882975644,0.08723006402232
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,18722,0.00362253943843833,0.0131132112160314,-0.0220793545449832,0.0293244334218598,0.782358240187182
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,18722,0.00275265527931209,0.0131040309943151,-0.0229312454695454,0.0284365560281696,0.833621791138324
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20718.Liking for sardines,18722,0.00341723667038916,0.0131329628030392,-0.0223233704235677,0.029157843764346,0.794710034689137
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),18722,-2.03335701516304e-05,0.0131675496057439,-0.0258287307974096,0.0257880636571064,0.998767909077912
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,18722,0.0253206324440807,0.0132951759030683,-0.000737912325933211,0.0513791772140946,0.0568607208458089
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18722,-0.00775066081248466,0.0131238482848851,-0.0334734034508595,0.0179720818258901,0.554810104473904
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,18722,0.00149768469798204,0.0131579196452389,-0.0242918378066862,0.0272872072026503,0.909378676423813
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,18722,-0.000279415668236091,0.0131951715917043,-0.0261419519879764,0.0255831206515042,0.983105804679062
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,18722,0.029389963864448,0.0131477206072845,0.00362043147417029,0.0551594962547257,0.0254051063881811
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,18722,-0.0120720130664636,0.0131808819735365,-0.0379065417345951,0.0137625156016679,0.359745354354535
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,18722,-0.0255800019711031,0.0132473337770756,-0.0515447761741712,0.000384772231965043,0.0535037476075233
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,18722,-0.0249472854696702,0.0132264623285308,-0.0508711516335905,0.000976580694250155,0.0592882558512885
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20728.Liking for spinach,18722,-0.00135812880786979,0.0132642207414557,-0.027356001461123,0.0246397438453834,0.918447904797882
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20729.Liking for spirits,18722,0.000418584848439215,0.0131386739224973,-0.0253332160396554,0.0261703857365338,0.974584845271751
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,18722,0.0155713567935884,0.0143659810091319,-0.0125859659843101,0.0437286795714868,0.278420954929833
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18722,0.00827873643775337,0.0134595639553092,-0.0181020089146527,0.0346594817901594,0.538508008467599
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,18722,0.0206384671355946,0.0131304322766914,-0.00509718012672055,0.0463741143979097,0.116012912294976
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,18722,0.014589991623748,0.013460835792704,-0.0117932465299518,0.0409732297774477,0.278429976367492
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,18722,0.00150305590663908,0.0159592903061036,-0.029777153093324,0.0327832649066021,0.924966685895575
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,18722,-0.00686456368766813,0.0138027934999262,-0.0339180389475234,0.0201889115721871,0.618961165286049
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,18722,0.0208678439175963,0.0131282866019316,-0.00486359782218961,0.0465992856573823,0.111957030706469
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,18722,-0.00228083411319968,0.0132174944102755,-0.0281871231573397,0.0236254549309404,0.862997778691351
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),18722,-0.0119930561032091,0.0131310442048423,-0.0377299027447,0.0137437905382817,0.361077601367381
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,18722,0.0253751391487044,0.0144966822615408,-0.00303835808391555,0.0537886363813244,0.0800639724901581
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,18722,-0.0210074340264096,0.013141446986755,-0.0467646701204494,0.00474980206763027,0.109934579742734
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20741.Liking for watching television,18722,-0.00209080262133291,0.0132926746230887,-0.0281444448825867,0.0239628396399209,0.875018127913842
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20742.Liking for whisky,18722,-0.00695526425824542,0.0136315037996275,-0.0336730117055152,0.0197624831890244,0.609893169664016
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20743.Liking for white bread,18722,0.00358631241514209,0.0130567220816559,-0.0220048628649035,0.0291774876951877,0.78357148828448
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20744.Liking for white rice,18722,-0.00363569875986819,0.0132596383966328,-0.0296245900172685,0.0223531924975321,0.783939409715871
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20745.Liking for white wine,18722,-0.0016590655512589,0.0130875766480791,-0.027310715781494,0.0239925846789762,0.899126618298193
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18722,0.0285338555118818,0.0132959065016849,0.00247387876857943,0.0545938322551842,0.0318807684706879
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,18722,0.0108984176561808,0.0130910709556372,-0.0147600814168682,0.0365569167292297,0.405133053641711
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,18722,0.0103837664157632,0.0137102834379642,-0.0164883891226466,0.037255921954173,0.448837372243454
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,18722,0.00818233144750005,0.0132056063559611,-0.0177006570101837,0.0340653199051837,0.535521847087575
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21001.Body mass index (BMI),51485,0.0688777607108358,0.019130141897179,0.0313826825923649,0.106372838829307,0.000317924371843126
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21002.Weight,51525,-0.0467091941047996,0.0108025344663028,-0.0678821616587531,-0.0255362265508461,1.53574932725457e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,17148,0.0110981957753037,0.00764527994314244,-0.00388655291325553,0.0260829444638628,0.146619981415924
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17891,-0.019963161156862,0.0141042833263551,-0.0476075564765181,0.00768123416279403,0.156969535717023
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17908,-0.00874903633392633,0.0146369249916474,-0.0374374093175553,0.0199393366497027,0.550022784365531
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17910,-0.000311299300007683,0.0144132514005676,-0.0285612720451202,0.0279386734451049,0.982768764811857
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,17834,-0.0286019294720289,0.013393949071101,-0.0548540696513868,-0.00234978929267097,0.0327389622387707
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17813,-0.025420766566424,0.0142585700087318,-0.0533675637835383,0.00252603065069033,0.0746291976734228
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,17822,-0.00159358689930336,0.0144345647011187,-0.0298853337134959,0.0266981599148892,0.912092795339938
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,17698,0.0118197784884974,0.0143570866696497,-0.0163201113840161,0.0399596683610109,0.41036479022117
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,17761,0.0140707276501853,0.0160716066720031,-0.0174296214269408,0.0455710767273114,0.381312545885601
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17919,0.00440701456118759,0.0145192240643517,-0.0240506646049417,0.0328646937273169,0.761489805025166
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17909,-0.0146831426867048,0.0146207322521026,-0.0433397779008259,0.0139734925274164,0.315262731751645
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,10075,-0.0134186291741956,0.0226922837030214,-0.0578955052321176,0.0310582468837264,0.554312587609413
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17914,-0.00613878783969988,0.0158720153719033,-0.0372479379686304,0.0249703622892306,0.698932558004235
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17911,0.00771530662268856,0.0219864269390896,-0.035378090177927,0.0508087034233041,0.725658309025029
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17912,0.0118145929546863,0.0171623111204353,-0.0218235368413669,0.0454527227507395,0.491207719789124
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17910,0.0548212289737951,0.0425847740393086,-0.0286449281432497,0.13828738609084,0.197991262691189
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17918,0.00765645354723129,0.0167115629279844,-0.0250982097916182,0.0404111168860808,0.646848047718557
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17915,-0.00997885039747237,0.0166259734326787,-0.0425657583255226,0.0226080575305778,0.548382910764585
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17506,-0.0176621659108654,0.0151515706901565,-0.0473592444635721,0.0120349126418414,0.243752191623093
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17908,0.0223649435991145,0.0149437395125716,-0.00692478584552592,0.0516546730437549,0.134512515945323
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17916,0.0224670746928708,0.0216743645582178,-0.0200146798412361,0.0649488292269776,0.299948611185418
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17918,-0.00299874080852411,0.0145720761069466,-0.0315600099781395,0.0255625283610913,0.836959797951834
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17915,-0.0252702633120013,0.0145714228707486,-0.0538302521386686,0.003289725514666,0.0828937113168021
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),51210,0.0399091070471177,0.00848845449013498,0.0232717362464532,0.0565464778477823,2.58833668711748e-06
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,44678,-0.00469818922539159,0.00493897617646018,-0.0143785825312535,0.00498220408047036,0.341483848477376
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,41455,-0.00707195733082401,0.00961303096141322,-0.0259134980151939,0.0117695833535459,0.461939587337433
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22032.IPAQ activity group,41401,-0.010778007125671,0.00939202664034214,-0.0291863793407416,0.00763036508939959,0.251152792845859
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22033.Summed days activity,42494,-0.00392523142313559,0.00481404271629202,-0.013360755147068,0.00551029230079678,0.41486447912205
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22034.Summed minutes activity,41401,-0.00278556859223467,0.00485515649049785,-0.0123016753136105,0.00673053812914112,0.566150901261541
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22037.MET minutes per week for walking,39643,-0.00494927287854056,0.00494921831634509,-0.0146497407785769,0.00475119502149582,0.317311278654112
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,41401,0.00246236652552506,0.0048601929762981,-0.00706361170801922,0.0119883447590693,0.612410373183734
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,41401,-0.0141553554134397,0.00937484475358268,-0.0325300511304618,0.00421934030358235,0.131069027882055
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,39643,-0.00387898252653026,0.00496932899991773,-0.013618867366369,0.0058609023133085,0.435051415566307
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,43970,-0.00379784516194722,0.00479013651605202,-0.0131865127334092,0.00559082240951474,0.427871273517098
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X22501.Year ended full time education,12583,0.000964277313748736,0.0219790580910713,-0.0421146765447511,0.0440432311722485,0.965006693485486
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,12501,0.0688420546600897,0.0343631032118536,0.0014903723648567,0.136193736955323,0.0451590219346704
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,48330,0.0142084702378246,0.0220958969957698,-0.0290994878738842,0.0575164283495333,0.520203410077612
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23098.Weight,50657,-0.0446924701786722,0.0109000467701976,-0.0660565618482594,-0.023328378509085,4.13420560816508e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23099.Body fat percentage,50628,0.0748505589146913,0.0104564983481537,0.0543558221523101,0.0953452956770726,8.28018532014732e-13
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23100.Whole body fat mass,50575,0.0296459749494188,0.0101050543672518,0.00984006838960524,0.0494518815092323,0.00335015185878429
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23101.Whole body fat-free mass,50651,-0.0744315601080631,0.00911632840929781,-0.0922995637902868,-0.0565635564258393,3.29749380754893e-16
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23102.Whole body water mass,50657,-0.0747680385548662,0.00912840691385498,-0.092659716106022,-0.0568763610037104,2.65716450818073e-16
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23104.Body mass index (BMI),50657,0.0722574445200806,0.0192434955660223,0.034540193210677,0.109974695829484,0.000173602998415961
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23105.Basal metabolic rate,50655,-0.0757805729603918,0.00975397926126481,-0.0948983723124709,-0.0566627736083128,8.04660381495768e-15
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23106.Impedance of whole body,50651,0.05806492186902,0.00746307696797595,0.0434372910117871,0.0726925527262528,7.37205920884905e-15
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23107.Impedance of leg (right),50654,0.068943158929915,0.00608602185297612,0.0570145560980818,0.0808717617617482,1.0341317678762e-29
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23108.Impedance of leg (left),50653,0.0666957415520462,0.00604284299529537,0.0548517692812673,0.0785397138228251,2.72460050223377e-28
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23109.Impedance of arm (right),50644,0.0236220633357551,0.00743916261724775,0.00904130460594953,0.0382028220655607,0.00149737310980722
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23110.Impedance of arm (left),50652,0.0219161810327114,0.00744786006691482,0.00731837530155841,0.0365139867638645,0.00325600925767101
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23111.Leg fat percentage (right),50653,0.126832523557419,0.0126482296428745,0.102041993457384,0.151623053657453,1.21186992359801e-23
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23112.Leg fat mass (right),50652,0.0680786022684848,0.0134590469885955,0.0416988701708377,0.094458334366132,4.24699250962202e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),50651,-0.0969934442248318,0.00953741478082152,-0.115686777195242,-0.0783001112544216,2.85447934171189e-24
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23114.Leg predicted mass (right),50650,-0.0976970614099538,0.00958491528864956,-0.116483495375707,-0.0789106274442007,2.25440395221094e-24
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23115.Leg fat percentage (left),50647,0.12937198456011,0.0131805965279579,0.103538015365313,0.155205953754908,1.01340468823191e-22
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23116.Leg fat mass (left),50647,0.0646945367669151,0.0140358621300952,0.0371842469919284,0.0922048265419017,4.05145228199289e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),50644,-0.095048377789786,0.00995445727674102,-0.114559114052198,-0.0755376415273736,1.37450801148941e-21
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23118.Leg predicted mass (left),50643,-0.0952002621639856,0.0100046104229289,-0.114809298592926,-0.0755912257350448,1.88219047364172e-21
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23119.Arm fat percentage (right),50643,0.0474068652623907,0.0116045389736669,0.0246619688740037,0.0701517616507778,4.41065401530607e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23120.Arm fat mass (right),50638,0.0130004566091326,0.0114984686010231,-0.0095365418488727,0.0355374550671378,0.258218296876224
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),50639,-0.0486733111250658,0.00917851895993634,-0.066663208286541,-0.0306834139635906,1.14417420424721e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23122.Arm predicted mass (right),50638,-0.0494067072703181,0.00919281375414552,-0.0674246222284433,-0.0313887923121929,7.71374092631287e-08
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23123.Arm fat percentage (left),50633,0.0429688565809031,0.0118986773634428,0.0196474489485552,0.066290264213251,0.000305043050790378
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23124.Arm fat mass (left),50632,0.0142337948194192,0.0114709010811941,-0.00824917129972122,0.0367167609385596,0.21466281975188
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),50628,-0.042510347333046,0.00935820025343013,-0.060852419829769,-0.024168274836323,5.5698749555527e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23126.Arm predicted mass (left),50625,-0.0404839848611758,0.00939098635142597,-0.0588903181099707,-0.0220776516123809,1.62868370281639e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23127.Trunk fat percentage,50621,0.0383803231828386,0.00749822957696612,0.023683793211985,0.0530768531536922,3.08961054196667e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23128.Trunk fat mass,50617,0.0160019094767949,0.00825488981946921,-0.000177674569364735,0.0321814935229546,0.0525706755974545
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23129.Trunk fat-free mass,50610,-0.0587125034555422,0.00826511956236262,-0.074912137797773,-0.0425128691133115,1.23103966273699e-12
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23130.Trunk predicted mass,50605,-0.0586753102530765,0.0082699375680481,-0.0748843878864507,-0.0424662326197022,1.31033107485955e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,29581,0.0770856656986146,0.00593620147681321,0.0654507108040607,0.0887206205931685,1.87958065343266e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,29581,0.0839784178025126,0.00574793335604925,0.072712468424656,0.0952443671803691,3.56111644373134e-48
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",29581,0.0848997528062962,0.00575860568445022,0.0736128856647737,0.0961866199478186,5.08909322109684e-49
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,29581,0.0960356620597258,0.00576520516925544,0.0847358599279851,0.107335464191466,5.09599953520949e-62
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,29581,0.070839134677894,0.0057601376766637,0.0595492648316332,0.0821290045241549,1.12636277742409e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,29581,0.0801193020702216,0.00573989925960766,0.0688690995213906,0.0913695046190526,3.86677729711797e-44
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,29581,-0.00445450539867595,0.00669536586557671,-0.0175774224952063,0.0086684116978544,0.505856323783177
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,29581,0.113407432072477,0.00610212671006806,0.101447263720743,0.12536760042421,1.16518915587104e-76
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,29581,0.108470071875332,0.00615180470919933,0.0964125346453014,0.120527609105363,3.15374348488132e-69
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,29581,0.120822571078572,0.00590581673483919,0.109247170278287,0.132397971878857,2.21665766062334e-92
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,29581,0.107684911636829,0.00588097504352969,0.0961582005515104,0.119211622722147,1.75551002637494e-74
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,29581,0.0960155825149261,0.00601628036334015,0.0842236730027794,0.107807492027073,4.25363185125496e-57
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,29581,0.106917002335935,0.00589468113492601,0.0953634273114798,0.11847057736039,3.99291115182323e-73
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,29581,0.0806908331934947,0.00572658821713436,0.0694667202879114,0.0919149460990781,6.06954168288594e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,29581,0.0339452582359449,0.00645633164096182,0.0212908482196597,0.04659966825223,1.46905121588247e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,29581,0.0748379729381332,0.00596720106867155,0.0631422588435369,0.0865336870327294,5.46177703922375e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,29581,0.088920445849923,0.00573553640539878,0.0776787944953414,0.100162097204505,5.36797202138931e-54
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,29581,0.0865327409204217,0.00572517332450689,0.0753114012043882,0.0977540806364552,2.02565205620938e-51
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,29581,-0.0115131146608569,0.00667258722937957,-0.0245913856304408,0.00156515630872705,0.0844595810130489
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,29581,0.0811686967897742,0.00586354619218652,0.0696761462530887,0.0926612473264598,1.91817158291712e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,29581,0.103656063012556,0.00583992826539539,0.0922098036123806,0.115102322412731,4.01930895938894e-70
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,29581,0.0601494484635854,0.00580463963867651,0.0487723547717794,0.0715265421553913,4.06302763296254e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,29581,0.0189159654563513,0.00669382434752928,0.00579606973519389,0.0320358611775087,0.0047182067707475
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,29581,0.103537546225271,0.0058029236959565,0.0921638157811967,0.114911276669346,7.80885856179379e-71
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,29581,0.110300357632014,0.00597069894762516,0.0985977876946687,0.122002927569359,9.00074686966777e-76
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,29581,0.0851826248447882,0.00572942036628135,0.0739529609268767,0.0964122887626996,8.10207517810514e-50
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,29581,0.0262681001681522,0.00654833080208788,0.01343337179606,0.0391028285402445,6.05031807876455e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,29581,0.0725150317522057,0.00613399071763483,0.0604924099456415,0.08453765355877,3.55739451877535e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,29581,0.103117490425446,0.00581141752683641,0.0917271120728464,0.114507868778045,4.43568451562434e-70
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,29581,0.0772786621490881,0.0057178092740848,0.0660717559718819,0.0884855683262943,1.68465415495745e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,29581,0.0620326469567144,0.00615913897390379,0.049960734567863,0.0741045593455659,8.05599626212982e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,29581,0.0934221044915403,0.00640132940861996,0.0808754988506452,0.105968710132435,4.49704528810356e-48
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,29581,-0.0416176786788393,0.00600572098081524,-0.0533888918012372,-0.0298464655564415,4.30458514819389e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,29581,-0.0727949587296969,0.00684702748095093,-0.0862151325923607,-0.0593747848670331,2.37017679433033e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,29558,0.0951421732057242,0.00605792496075141,0.0832686402826514,0.107015706128797,2.32707211376246e-55
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,29558,0.0884422112690025,0.00649616796841872,0.0757097220509018,0.101174700487103,4.39897248083755e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23436.Total Cholines,29558,0.0922761782183585,0.00611334235901729,0.0802940271946846,0.104258329242032,2.74666520295273e-51
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,29558,0.0791885058247134,0.00614433811616375,0.0671456031170324,0.0912314085323943,6.65085603879562e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,29557,0.084514785501348,0.00615816703920055,0.0724447781045149,0.0965847928981811,9.86275817292978e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,29581,0.0796754104298827,0.00572387321880284,0.0684566189210291,0.0908942019387363,6.60525519898047e-44
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,29581,0.0441320048711348,0.0063706536249077,0.0316455237663157,0.0566184859759539,4.37445523035508e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,29581,0.0492107159724877,0.00585261948768929,0.0377395817766167,0.0606818501683587,4.34354735717316e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,29558,0.121159217702961,0.0058092802161013,0.109773028479403,0.13254540692652,6.59141408201474e-96
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,29558,-0.0761432928492232,0.00631046862281761,-0.0885118113499457,-0.0637747743485007,1.91010323535167e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,29558,0.0279818572689584,0.0059634560040105,0.0162934835010978,0.039670231036819,2.71463816498237e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,29558,0.0968378451093481,0.00582737774400689,0.0854161847310946,0.108259505487602,9.89211498518056e-62
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,29558,0.0893636845952664,0.00586068243347402,0.0778767470256573,0.100850622164876,2.68621543421627e-52
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,29558,0.131204215994004,0.0059497392850534,0.119542726995299,0.142865704992709,6.65575928209231e-107
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,29558,0.125782546441231,0.0058367084769356,0.114342597826437,0.137222495056025,3.23040921227624e-102
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,29558,0.0929832086030981,0.00580783778747134,0.0815998465396543,0.104366570666542,1.90075419897912e-57
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,29558,-0.00232285241165809,0.00613396389478172,-0.0143454216454303,0.00969971682211408,0.704923026096961
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,29558,-0.0387480129085131,0.00601014994827917,-0.0505279068071403,-0.0269681190098859,1.15771667647642e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,29558,-0.101896943565567,0.00623892424561029,-0.114125235086963,-0.0896686520441707,1.06006470125553e-59
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,29558,-0.123550408068971,0.00634321416536765,-0.135983107833092,-0.111117708304851,5.72885909266589e-84
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,29558,0.112510862930321,0.00646240341721597,0.0998445522325773,0.125177173628064,1.50557844265003e-67
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,29558,0.074136414798753,0.00586218454443638,0.0626465330916577,0.0856262965058483,1.45422046983691e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,29558,-0.0425705213180243,0.00625318082802375,-0.0548267557409508,-0.0303142868950977,1.00983641873942e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,29558,-0.0793617065375305,0.006147459036438,-0.0914107262489489,-0.067312686826112,5.03110504926737e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,29558,-0.124123575985692,0.00645806466542977,-0.136781382729934,-0.11146576924145,7.97261598541132e-82
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,29556,0.0099348994679027,0.00595321019274999,-0.00173339250988729,0.0216031914456927,0.0951615486852773
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23460.Alanine,29571,0.0813743063589598,0.00581660623326268,0.069973758141765,0.0927748545761546,2.48537272627029e-44
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23461.Glutamine,29492,-0.131573719350805,0.00574607957238983,-0.142836035312689,-0.120311403388921,4.91549935655757e-115
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23462.Glycine,29546,0.0473446252010527,0.00613686127381382,0.0353163771043776,0.0593728732977277,1.24985742079203e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23463.Histidine,29544,0.0238988745436186,0.00576243380055864,0.0126045042945237,0.0351932447927136,3.37273704228972e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),29560,0.0601370334557741,0.00610727708063233,0.0481667703777347,0.0721072965338135,7.67442670216464e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23465.Isoleucine,29575,0.0342994381886978,0.00596364951749965,0.0226106851343984,0.0459881912429971,8.93697499314459e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23466.Leucine,29576,0.0526776854845419,0.00609261479476347,0.0407361604868055,0.0646192104822783,5.59076568024172e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23467.Valine,29560,0.0677249284444237,0.00611674064923271,0.0557361167719276,0.0797137401169198,1.9498834487838e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23468.Phenylalanine,29570,0.0253207838085502,0.00582862314351611,0.0138966824472586,0.0367448851698417,1.40240944266424e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23469.Tyrosine,29548,0.0456284362406278,0.00592163581090664,0.0340220300512508,0.0572348424300048,1.34537727993101e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23470.Glucose,29528,-0.0491831774351501,0.00585697679779567,-0.0606628519588296,-0.0377035029114706,4.7678124215038e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23471.Lactate,29528,0.235383594998424,0.00563971199408848,0.224329759490011,0.246437430506838,0
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23472.Pyruvate,29491,0.115598885750998,0.00575326997973996,0.104322476590708,0.126875294911288,3.38463227745654e-89
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23473.Citrate,29576,0.0395015558880829,0.00587437758798067,0.0279877758156407,0.051015335960525,1.79548163746801e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,29101,0.064742539761148,0.00589748847084758,0.0531834623582867,0.0763016171640092,5.53471144578976e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23475.Acetate,29555,-0.127562117093233,0.005749635294322,-0.138831402270104,-0.116292831916362,3.58244746386907e-108
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23476.Acetoacetate,29579,-0.0103627450039343,0.0058046162390591,-0.0217397928324901,0.00101430282462156,0.0742295186753107
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23477.Acetone,29579,-0.0518458302230188,0.00579311550769889,-0.0632003366181087,-0.040491323827929,3.77270374391215e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23478.Creatinine,28838,0.0251206519847075,0.00687678984499904,0.0116421438885094,0.0385991600809056,0.000259691866406278
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23479.Albumin,29577,0.0621265909153802,0.00585690007493463,0.0506470667685084,0.0736061150622521,3.06849045146242e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,29581,0.224855636265661,0.0060240982105188,0.213048403773044,0.236662868758277,5.18507736519131e-298
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,29581,0.099196489288144,0.00617902693840165,0.0870855964888767,0.111307382087411,9.44782232108471e-58
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,29581,0.0947601233440537,0.00616838611716027,0.0826700865544196,0.106850160133688,4.70470619713009e-53
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,29581,0.101927223604745,0.0062009358430851,0.0897733893522979,0.114081057857191,1.91591007299717e-60
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,29581,0.107519757547571,0.00613835087734431,0.0954885898279762,0.119550925267166,2.39406073827765e-68
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,29581,0.109376212006097,0.00611390101468445,0.097392966017315,0.121359457994878,3.36670437438528e-71
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,29581,0.102603892969871,0.00614385877061396,0.0905619297794674,0.114645856160274,2.52145047087317e-62
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,29581,0.0846217979499795,0.00614808776554948,0.0725715459295025,0.0966720499704564,5.70129144909251e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,29581,0.11127214303273,0.00620128577591527,0.0991176229119356,0.123426663153524,1.29727048852287e-71
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,29581,0.10899736474468,0.00619218472835527,0.0968606826771036,0.121134046812256,5.3136349719866e-69
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,29581,0.106644065716009,0.0061565794214466,0.0945771700499735,0.118710961382044,6.87593180542984e-67
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,29581,0.106297079730909,0.00602465112223439,0.0944887635313297,0.118105395930489,2.58059408233345e-69
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,29581,0.103546112081117,0.00594209971576812,0.0918995966382111,0.115192627524022,1.14523552195882e-67
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,29581,0.104893409941214,0.00610557030831276,0.0929264921369206,0.116860327745507,7.83817406681449e-66
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,29581,0.106613760941789,0.00625315126140149,0.0943575844694423,0.118869937414136,7.19147186340695e-65
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,29581,0.109336128677611,0.00612331793096533,0.0973344255329193,0.121337831822303,6.15962655196829e-71
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,29581,0.106705094200351,0.00611290531765682,0.0947237997777439,0.118686388622959,6.82764865805071e-68
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,29581,0.109012196762202,0.00614467732898366,0.0969686291973945,0.12105576432701,4.67907339964974e-70
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,29581,0.106734771112138,0.00599460599185265,0.0949853433681073,0.11848419885617,1.50714707448335e-70
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,29581,0.0992347854305813,0.00588877589398847,0.0876927846783639,0.110776786182799,2.02318527645503e-63
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,29581,0.111785632046015,0.00611352096467253,0.0998031309552564,0.123768133136773,2.80067506370811e-74
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,29581,0.101340889254752,0.0061427662505099,0.0893010674037526,0.113380711105751,7.14758562027188e-61
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,29581,0.0941367996396734,0.00576182417388317,0.0828436242588624,0.105429975020484,9.67942730023984e-60
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,29581,0.100621206631701,0.00580808272513956,0.0892373644904279,0.112005048772975,6.60071547179788e-67
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,29581,0.0919075262520305,0.00574901407035228,0.08063945867414,0.103175593829921,2.75307430624294e-57
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,29581,0.0652833417597675,0.00574430660224801,0.0540245008193614,0.0765421827001735,7.2155029141436e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,29581,0.0476223840271121,0.00580784950448597,0.0362389989983196,0.0590057690559046,2.50731185008622e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,29581,0.0839679965466807,0.00573007297187925,0.0727370535217974,0.0951989395715641,1.88139066424278e-48
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,29581,0.108752352944396,0.00602580899065653,0.0969417673227092,0.120562938566083,2.01265677938345e-72
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,29581,0.104862277672426,0.00588163089769735,0.0933342811129395,0.116390274231913,9.92220708317412e-71
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,29581,0.108691423184979,0.00585726236941911,0.0972111889409178,0.120171657429041,1.95854974592512e-76
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,29581,0.0981264552708813,0.00576115640121945,0.0868345887244912,0.109418321817271,9.61992400542743e-65
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,29581,0.0911198287506789,0.00574779738907148,0.0798541458680988,0.102385511633259,2.2890616638145e-56
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,29581,0.0937404877263968,0.00577164087760727,0.0824280716062866,0.105052903846507,4.62039782370369e-59
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,29581,0.0847939363021301,0.00572474289553835,0.0735734402268749,0.0960144323773852,1.84855829650313e-49
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,29581,0.108019729322839,0.00604428027015714,0.0961729399933306,0.119866518652347,4.66343745519358e-71
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,29581,0.0855346135574888,0.00580783595026155,0.0741512550949761,0.0969179720200014,6.4058174253359e-49
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,29581,0.0839685295318448,0.00582826268933322,0.0725451346607517,0.0953919244029379,6.73035326619897e-47
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,29581,0.0803118161135465,0.00582116152218373,0.0689023395300664,0.0917212926970266,3.63974634631347e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,29581,0.0642265717112158,0.00590923568431601,0.0526444697699564,0.0758086736524752,1.82864605257372e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,29581,0.0582570204618247,0.00595679445530675,0.0465817033294235,0.0699323375942259,1.48564908481955e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,29581,0.0758156758470644,0.00583090785737828,0.064387096446603,0.0872442552475258,1.51307166077533e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,29581,0.103495671318001,0.00595029654935744,0.0918330900812601,0.115158252554741,2.00813331228144e-67
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,29581,0.0624602961448684,0.00579780592405533,0.0510965965337199,0.0738239957560168,5.17742468471671e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,29581,0.0681645007895834,0.00594440946468416,0.0565134582388025,0.0798155433403644,2.24080209023848e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,29581,0.0648699840336475,0.00595198072328095,0.0532041018160168,0.0765358662512781,1.31676484326239e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,29581,0.0588434901386448,0.00597179595044415,0.0471387700757743,0.0705482102015153,7.1747121141782e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,29581,0.0589527233665383,0.00596951558267296,0.0472524728244993,0.0706529739085773,5.76296753094734e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,29581,0.056827403434078,0.0059689988741595,0.0451281656407253,0.0685266412274306,1.85135009186584e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,29581,0.105956819917772,0.00589380561211029,0.0944049609180362,0.117508678917509,7.04489148441269e-72
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,29581,0.0672091915733472,0.00573223723907062,0.0559740065847688,0.0784443765619256,1.11843493223365e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,29581,0.0798098308978357,0.00577493931852687,0.068490949833523,0.0911287119621483,2.63215276981805e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,29581,0.078024950264031,0.00576796880588314,0.0667197314045,0.089330169123562,1.43538328968378e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,29581,0.0736244304799989,0.0057920715333261,0.0622719702746797,0.0849768906853181,6.39859776077259e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,29581,0.0784426236067972,0.00577005658875036,0.0671333126928465,0.0897519345207479,5.75186025908008e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,29581,0.058531550973394,0.00586454384457988,0.0470370450380174,0.0700260569087705,2.01903302641389e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,29581,0.118344700775503,0.00588274800093243,0.106814514693676,0.129874886857331,2.07001938525357e-89
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,29581,0.0914626111892524,0.00571795881794112,0.0802554119060878,0.102669810472417,2.38504778391008e-57
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,29581,0.0960226365036226,0.00571081405316364,0.0848294409594219,0.107215832047823,3.77866567493293e-63
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,29581,0.0911840596007865,0.00570768334568071,0.0799970002432523,0.102371118958321,3.27894221108607e-57
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,29581,0.092311151687623,0.00570879117704118,0.0811219209806223,0.103500382394624,1.4649494113075e-58
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,29581,0.0994968725217922,0.00572081206421497,0.0882840808759309,0.110709664167654,2.05283505728629e-67
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,29581,0.0679311747268962,0.0057312192114899,0.056697985072376,0.0791643643814164,2.46276749688644e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,29581,0.122980129415419,0.00593643196361563,0.111344722766732,0.134615536064105,1.16617040345343e-94
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,29581,0.0831562233145502,0.0057200609053306,0.0719449039401022,0.0943675426889982,1.02238378540753e-47
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,29581,0.0818211773742924,0.00571285875178255,0.0706239742207986,0.0930183805277862,2.27093612411428e-46
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,29581,0.0596700965480003,0.00571738091886956,0.048464029947016,0.0708761631489846,1.86821656461399e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,29581,0.0818943176531274,0.00570934045319148,0.0707040103648721,0.0930846249413827,1.66650499119689e-46
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,29581,0.093141107216118,0.00571587185977605,0.081937998370957,0.104344216061279,1.94045134760316e-59
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,29581,0.0458935202001142,0.00573920507999381,0.0346446782433264,0.0571423621569021,1.32650490106301e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,29581,0.117904194936657,0.00600733560902683,0.106129817142964,0.129678572730349,3.19327283651666e-85
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,29581,-0.048604012494193,0.0067441358264207,-0.0618225187139775,-0.0353855062744084,5.8629188693146e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,29581,-0.0707898457113309,0.0067669287041008,-0.0840530259713684,-0.0575266654512933,1.44378688525945e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,29581,-0.076493660768353,0.00674739038474765,-0.0897185459224584,-0.0632687756142476,9.93675500830661e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,29581,-0.074970386766623,0.00677651041076832,-0.0882523471717289,-0.0616884263615171,2.14968154462431e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,29581,-0.075799066247994,0.00685043526440341,-0.0892259193662247,-0.0623722131297633,2.11226873045979e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,29581,-0.0677884143523385,0.00643646951109543,-0.0804038945940855,-0.0551729341105914,6.84215663144694e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,29581,0.0786286990490347,0.00582298081655399,0.0672156566485889,0.0900417414494805,1.98791986154522e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,29581,-0.0520011542045391,0.0069717756761214,-0.065665834529737,-0.0383364738793411,8.97027093790744e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,29581,-0.0498137189439254,0.00692254316484963,-0.0633819035470307,-0.0362455343408202,6.35403832716208e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,29581,-0.0398428582650453,0.00684523230907229,-0.0532595135908269,-0.0264262029392636,5.92675825987916e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,29581,-0.0702958591056697,0.00696295102888237,-0.0839432431222792,-0.0566484750890603,6.31127241815836e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,29581,-0.0753490161660812,0.0069612358945013,-0.0889930385193037,-0.0617049938128586,2.97778752592622e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,29581,-0.0522804535425305,0.00692931170732032,-0.0658619044888783,-0.0386990025961827,4.65898765485975e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,29581,0.0685338098885357,0.0059589845476701,0.0568542001751023,0.0802134196019691,1.51594306039318e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,29581,0.0401977248699901,0.00631405837005387,0.0278221704646846,0.0525732792752957,1.96373170816652e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,29581,0.0480554996598239,0.0062336859327333,0.0358374752316667,0.0602735240879812,1.30773906483339e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,29581,0.0564402196572191,0.00616059354887096,0.044365456301432,0.0685149830130061,5.43974014355389e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,29581,0.0219107143004551,0.00636148499451451,0.00944220371120664,0.0343792248897035,0.000573383206716333
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,29581,0.0174134590165378,0.00634076869513231,0.00498555237407846,0.0298413656589971,0.00603136962274971
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,29581,0.0388522989677533,0.00641503449580926,0.0262788313559671,0.0514257665795394,1.40840510812339e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,29581,0.108207325954678,0.00588407313737946,0.0966745426054139,0.119740109303941,4.15849469571693e-75
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,29581,0.0996713244602681,0.00572527226024424,0.0884497908301894,0.110892858090347,1.53235829699868e-67
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,29581,0.112224636296962,0.00575701417145739,0.100940888520906,0.123508384073019,4.20552269850692e-84
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,29581,0.109509315693469,0.00578573379287247,0.0981692774594386,0.120849353927499,1.99961013125989e-79
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,29581,0.0902658786310717,0.00573270799413752,0.0790297709625621,0.101501986299581,1.23648421595422e-55
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,29581,0.0796476195620201,0.00572206954273844,0.0684323632582528,0.0908628758657875,6.64846039715759e-44
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,29581,0.109496078756851,0.00581653622028954,0.0980956677650832,0.120896489748618,1.3602245051954e-78
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,29581,0.126605037321638,0.00615454547423919,0.114542128192129,0.138667946451147,2.25389921356787e-93
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28320,0.0457024347508691,0.00590613165404227,0.0341264167089463,0.057278452792792,1.0423747693451e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28320,0.00745784352114095,0.00598964241549177,-0.00428185561322291,0.0191975426555048,0.213096726478573
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28320,0.0176816612917504,0.0059296049539129,0.0060596355820811,0.0293036870014197,0.00286682163258225
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28320,-0.012989767352867,0.00605219324697602,-0.02485206611694,-0.00112746858879405,0.0318582505349145
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28320,-0.0209680435947816,0.00590500689681084,-0.0325418571125309,-0.00939423007703239,0.000384550363343336
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,29271,0.0246920552750374,0.00576858768225432,0.0133856234178189,0.0359984871322559,1.87122793775629e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,29271,-0.0517913350764621,0.00628427062713251,-0.0641085055056418,-0.0394741646472824,1.77209324589422e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,29271,-0.0501415856227196,0.00627548219309174,-0.0624415307211794,-0.0378416405242598,1.39777984199661e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,29271,-0.0452322651046237,0.00610024042402932,-0.0571887363357211,-0.0332757938735262,1.25076817008394e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,29271,0.0359405697624246,0.00613198652405835,0.0239218761752703,0.047959263349579,4.64561958122189e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,29576,0.0765391011497931,0.00608650406700746,0.0646095531784585,0.0884686491211277,3.57755955527594e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,29576,-0.00305603090789484,0.00591783785576241,-0.0146549931051892,0.00854293128939949,0.605571914915407
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,29576,-0.0241082779714761,0.00613415320954048,-0.0361312182621755,-0.0120853376807768,8.50782068598436e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,29576,0.0465270018936857,0.00579076373677264,0.0351771049696114,0.0578768988177601,9.72800912065065e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,29576,-0.0288747164103201,0.00573613297272737,-0.0401175370368657,-0.0176318957837744,4.83597121735425e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,29581,-0.00511773326945389,0.00605091183564366,-0.0169775204673155,0.00674205392840769,0.397682969361233
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,29581,-0.04255259,0.006309371,-0.05491896,-0.03018623,1.565446e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,29581,-0.0489998602575581,0.00635359541688134,-0.0614529072746456,-0.0365468132404707,1.27597315617469e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,29581,-0.0236453176789112,0.00616619308894992,-0.035731056133253,-0.0115595792245694,0.000125993467599486
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,29581,0.0344165547139013,0.00626024442341407,0.0221464756440097,0.0466866337837929,3.880912100917e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,29581,-0.0293965120619791,0.00614399304187403,-0.0414387384240522,-0.017354285699906,1.72159350947775e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,29581,-0.0173262833736015,0.00596560920698364,-0.0290188774192895,-0.0056336893279136,0.0036827587215444
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,29581,-0.00569276891887986,0.00582622721407183,-0.0171121742584606,0.00572663642070093,0.328530844459727
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,29581,-0.0326610211429459,0.00617944042104584,-0.0447727243681958,-0.0205493179176961,1.26295980862953e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,29581,0.0211466014925348,0.0060231073565696,0.00934131107365834,0.0329518919114112,0.000447236646451156
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,29581,-0.017608607219363,0.00601354981967165,-0.0293951648659194,-0.00582204957280656,0.00341239807339601
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,29581,-0.0392606990905122,0.00627495535396203,-0.0515596115842778,-0.0269617865967467,3.98517497171562e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,29581,-0.0402564673840012,0.0063373695840201,-0.0526777117686806,-0.0278352229993218,2.15291592414441e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,29581,-0.021799773104333,0.00582008022955049,-0.0332071303542519,-0.010392415854414,0.000180294665316183
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,29581,0.0484332836412662,0.00623053363632654,0.0362214377140662,0.0606451295684663,7.87941313145184e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,29581,-0.0382011530559093,0.00572467915842129,-0.049421524206415,-0.0269807819054035,2.54937542605155e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,29581,-0.0164178251425669,0.00602812505913838,-0.0282329502584782,-0.0046027000266557,0.00646247750142744
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,29581,-0.0123421666242792,0.00598007131951913,-0.0240631064105367,-0.000621226838021717,0.0390375301803491
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,29581,-0.0200565824143449,0.00587011578035246,-0.0315620093438358,-0.00855115548485411,0.000634640973120052
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,29581,0.0382253293472963,0.00615331386815946,0.0261648341657038,0.0502858245288888,5.29592346835394e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,29581,-0.0285825898795782,0.00576620078078351,-0.0398843434099139,-0.0172808363492426,7.20156229506156e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,29581,-0.0246648783809685,0.00613128270200841,-0.036682192476905,-0.012647564285032,5.76550446743082e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,29581,0.0308996723182358,0.00573930889855133,0.0196506268770752,0.0421487177593964,7.34575317570179e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,29581,-0.0705863902955799,0.00631549494440894,-0.0829647603866214,-0.0582080202045383,6.0609050490719e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,29581,0.033900218713223,0.00605871286137358,0.0220251415049308,0.0457752959215152,2.22208752542731e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,29581,-0.0658905085951086,0.0057763208397734,-0.0772120974410645,-0.0545689197491528,4.45961108974978e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,29581,0.0139758705788293,0.00584358928246294,0.00252243558520196,0.0254293055724567,0.0167786453823661
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,29581,0.0817285295955275,0.00587955282152474,0.070204606065339,0.093252453125716,8.64509613576957e-44
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,29581,-0.086122772359535,0.00625982733351121,-0.098392033933217,-0.073853510785853,6.18381279383651e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,29581,0.0242537742374166,0.00593627133841717,0.0126186824141189,0.0358888660607142,4.40615165458407e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,29581,-0.118691734928719,0.00576596394076475,-0.129993024252618,-0.10739044560482,1.69861599295281e-93
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,29581,0.0534336276171891,0.00578139132707084,0.0421021006161302,0.0647651546182479,2.56831871279472e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,29581,0.110082806679203,0.00576731268873777,0.0987788738092771,0.121386739549129,9.84912612725282e-81
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,29581,-0.0675114295347494,0.00605108536936802,-0.0793715568587108,-0.0556513022107881,7.56572930833761e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,29581,0.0627701557881487,0.00607409006635579,0.0508649392580913,0.074675372318206,5.44983509251437e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,29567,-0.0863533297068037,0.00647759585504035,-0.0990494175826827,-0.0736572418309246,1.9982202777638e-40
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,29567,0.0137028558027793,0.00606111866898567,0.00182306321156741,0.0255826483939913,0.0237801254934731
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,29567,-0.00571898677588873,0.00582578955191006,-0.0171375342976324,0.00569956074585498,0.326271843698535
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,29567,0.0513817303685179,0.00683266045161524,0.037989715883352,0.0647737448536838,5.63219819949188e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,29567,0.122285125438242,0.00636328330755546,0.109813090155433,0.134757160721051,8.37952483099448e-82
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,29581,0.0855857320479764,0.00635268042288977,0.0731344784191124,0.0980369856768404,3.01037514616104e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,29581,-0.110228057378423,0.00650132823489077,-0.122970660718809,-0.0974854540380369,3.57442464559744e-64
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,29581,-0.109816515302638,0.00640061719997397,-0.122361725014587,-0.0972713055906892,1.15593846175722e-65
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,29581,-0.0381352881000461,0.00630617719859682,-0.0504953954092959,-0.0257751807907963,1.49066421828075e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,29581,0.0997600978430113,0.00626660840031217,0.0874775453783994,0.112042650307623,8.02110023216758e-57
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,29581,0.0529323290349647,0.0064388517978455,0.0403121795111875,0.0655524785587419,2.10385465994786e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,29581,-0.0792997160774074,0.00632316292493946,-0.0916931154102887,-0.0669063167445261,5.48973291120872e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,29581,-0.0858464184132151,0.00614812766741811,-0.0978967486413546,-0.0737960881850756,3.62122470714792e-44
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,29581,0.00197456204440614,0.00673022664555565,-0.0112166821808829,0.0151658062696952,0.76922830205666
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,29581,0.0897206266683103,0.00617251307153285,0.0776225010481059,0.101818752288515,1.05455145015578e-47
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,29581,-0.00889062444596692,0.00592342742137722,-0.0205005421918663,0.00271929329993242,0.133385458445784
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,29581,-0.0461615687437593,0.00591419854795714,-0.0577533978977553,-0.0345697395897633,6.13556703404449e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,29581,-0.0451023388695349,0.00587832226613106,-0.0566238505111518,-0.0335808272279181,1.73646557526436e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,29581,0.00557188193789203,0.00616607137212456,-0.00651361795147211,0.0176573818272562,0.366195991056777
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,29581,0.0879123707217827,0.0062809003092423,0.0756018061156678,0.100222935327898,2.2604638633607e-44
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,50976,0.00318170572819576,0.00499713983060018,-0.0066126883397806,0.0129760997961721,0.524319639642233
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,50976,-0.00322703202513136,0.00487813265989762,-0.0127881720385307,0.00633410798826798,0.508275351148558
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47550,0.00402784331673031,0.00466189476011852,-0.005109470413102,0.0131651570465626,0.387596227704086
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47550,-0.00754378159112846,0.00507483817406457,-0.017490464412295,0.0024029012300381,0.137151744635231
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47550,0.00464678038450741,0.00500262278136875,-0.00515836026697534,0.0144519210359902,0.35296178334909
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47550,0.00034266483479953,0.00459045610544114,-0.0086546291318651,0.00933995880146416,0.94049570855785
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,50976,-0.0438754992180924,0.018543200579761,-0.080220172354424,-0.00753082608176087,0.0179791750944876
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,50976,-0.00275570377267023,0.00436613058314026,-0.0113133197156251,0.00580191217028468,0.527942218698131
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,50976,0.00461800789475228,0.00436431189511998,-0.00393604341968289,0.0131720592091874,0.290001345915728
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,50976,-0.00235328845808798,0.00443632112958559,-0.0110484778720757,0.00634190095589976,0.595795729248439
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,50976,-0.0238980132019984,0.0129214265971604,-0.0492240093324328,0.00142798292843595,0.0643932795354304
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,50976,-0.0195021622430894,0.0125369590544185,-0.0440746019897497,0.00507027750357083,0.119815735717326
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,50976,0.0170899020210084,0.00498805090779352,0.00731332224173306,0.0268664818002837,0.000612643572675511
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,50976,0.0110171537435674,0.00498285500848471,0.0012507579269374,0.0207835495601975,0.0270394077514813
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,50976,0.0177908638308736,0.00492904599921344,0.00812993367241522,0.0274517939893319,0.00030720834736325
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,50873,0.037875675438393,0.00483943767186132,0.0283903776015448,0.0473609732752412,5.11428920595139e-15
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,50976,-0.00774938986956061,0.00438181694671316,-0.0163377510851184,0.000838971345997186,0.0769777453170781
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,50976,-0.00768355480741434,0.0043816659265746,-0.0162716200235006,0.00090451040867188,0.0795103481623293
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,50976,-0.00776470957381027,0.00438183985227827,-0.0163531156842757,0.000823696536655138,0.0763971460768473
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,50976,-0.00773567350305722,0.00438156537558211,-0.0163235416391982,0.00085219463308372,0.0774849975424087
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,50976,-0.00772741469138972,0.00438159889284525,-0.0163153485213664,0.000860519138586976,0.0778043052095093
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2405.Number of children fathered,23446,-0.000100319388773241,0.0140793083814156,-0.0276957638163477,0.0274951250388013,0.994314936644903
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45490,-0.0111443072081338,0.0051457664083054,-0.0212300093684124,-0.00105860504785522,0.0303375028285701
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45490,0.00604094307961075,0.00466204132705176,-0.00309665792141069,0.0151785440806322,0.195060589621894
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",45490,-0.0150446223983372,0.00463859446597251,-0.0241362675516433,-0.00595297724503103,0.0011821486922117
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45490,-0.0047715273559266,0.00484350469292229,-0.0142647965540543,0.0047217418422011,0.324560838597859
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45490,0.00255258993982772,0.00470256736637298,-0.00666444209826332,0.0117696219779188,0.587264847313182
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",45490,-0.0123220756437596,0.00466349503870854,-0.0214625259196283,-0.00318162536789084,0.00823877370813761
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51211,-0.0181654903212363,0.00491556897897462,-0.0278000055200266,-0.00853097512244604,0.000219682121030023
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51211,-0.0117900971556913,0.00462053991761677,-0.0208463553942202,-0.00273383891716246,0.0107236533629866
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,51211,0.0501842007916225,0.00438990661694074,0.0415799838224186,0.0587884177608263,3.15890493261155e-30
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,11255,0.00877858668240795,0.019259961972764,-0.0289709387842095,0.0465281121490254,0.648546491363461
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,21181,0.00214690401331123,0.0136603789211471,-0.0246274386721371,0.0289212466987595,0.875118008842611
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),27018,0.0176706262598756,0.0116632812515045,-0.00518940499307332,0.0405306575128244,0.129767712467081
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2734.Number of live births,27851,-0.00507810109640965,0.0112168534054254,-0.0270631337710435,0.0169069315782242,0.650753441464841
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2744.Birth weight of first child,22082,-0.027435199310863,0.0124673590409187,-0.0518712230310637,-0.00299917559066229,0.0277773556535289
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2754.Age at first live birth,18808,-0.0109698986353319,0.00755335285322188,-0.0257744702276467,0.003834672956983,0.146428855516208
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2764.Age at last live birth,18756,-0.00556249555594621,0.00729825879140203,-0.0198670827870942,0.00874209167520176,0.445969639547735
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,21373,-0.00314000781120623,0.0082338097715957,-0.0192782749635338,0.0129982593411213,0.702943344387919
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,19381,0.000700640549046628,0.00713288027994469,-0.013279804799645,0.0146810858977382,0.921753157919337
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,12633,0.00650484321059918,0.00890685330590682,-0.0109525892689782,0.0239622756901766,0.465208842625463
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19659,0.00791938454549068,0.0164790006438843,-0.0243794567165226,0.0402182258075039,0.630824421779358
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19650,0.0101020100177593,0.0182393610820603,-0.025647137703079,0.0458511577385976,0.579682564550263
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19690,0.00599480909204779,0.0188030602181775,-0.0308591889355801,0.0428488071196756,0.74986569274292
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19633,0.0149584904966561,0.0183615006015583,-0.0210300506823981,0.0509470316757103,0.415273402075563
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,19707,-0.00608835551613563,0.0160062770122532,-0.037460658460152,0.0252839474278807,0.703672661220142
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,19753,0.00958406974848384,0.0178245293854641,-0.0253520078470258,0.0445201473439935,0.590797203231518
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28741.Difficulty learning a new task,19597,0.0198963309176412,0.0202101483236854,-0.0197155597967822,0.0595082216320646,0.324895516085156
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,18890,0.00101909956047098,0.0202073562211884,-0.0385873186330583,0.0406255177540002,0.95977858457315
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,19622,0.0219403009426373,0.0172227770305357,-0.0118163420372126,0.0556969439224872,0.20270973530546
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19753,-0.0203938164340349,0.0243680660946766,-0.0681552259796011,0.0273675931115313,0.402654717088922
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11994,0.00664767799631411,0.0184423702078542,-0.0294993676110802,0.0427947236037084,0.718511902361823
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,12636,0.0265284638265713,0.00928920217912706,0.00832162755548223,0.0447353000976603,0.0042993342542958
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17622,-0.014207866332979,0.0156645997732073,-0.0449104818884653,0.0164947492225073,0.36441669964496
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17622,0.0183103532462987,0.0170701075441408,-0.0151470575402173,0.0517677640328147,0.283440190316323
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17622,0.0458497990651168,0.0570118062175913,-0.0658933411213622,0.157592939251596,0.421283175141905
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17622,0.00438711717177202,0.0586751080487812,-0.110616094603839,0.119390328947383,0.940398841005984
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17622,0.0677069489456586,0.064724389711837,-0.0591528548895419,0.194566752780859,0.295538034565463
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17622,0.0869972662677513,0.0549103251287803,-0.0206269709846581,0.194621503520161,0.113131668150906
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17622,-0.0271248005503882,0.0246125703180398,-0.0753654383737462,0.0211158372729697,0.270445859204245
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17622,-0.010252705542217,0.0442814605413998,-0.0970443682033605,0.0765389571189265,0.816901930914307
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,17506,-0.00200995126174455,0.0190499144385469,-0.0393477835612965,0.0353278810378073,0.915972562418222
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29003.Recent feelings of depression,17489,0.00739245638663488,0.018472372663728,-0.028813394034272,0.0435983068075418,0.689021568618247
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17515,0.022141655407826,0.0149104295393404,-0.00708278648928125,0.0513660973049332,0.137567743719861
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,17523,-0.000574229739502501,0.0149795051793764,-0.0299340598910802,0.0287856004120752,0.969421532932006
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,17536,-0.0034212877293115,0.0208222031517032,-0.0442328059066498,0.0373902304480268,0.869489325505257
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,17467,0.0117039948407074,0.0200451191100631,-0.0275844386150163,0.0509924282964312,0.55930689490049
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,17533,0.00120955757556379,0.0198018037287183,-0.0376019777327241,0.0400210928838516,0.951293643953626
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17516,-0.0313623012445034,0.0347616068822418,-0.0994950507336972,0.0367704482446904,0.366957253512216
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,17431,0.0146071764682872,0.0384357633429191,-0.0607269196838343,0.0899412726204086,0.703919411959804
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,16133,-0.015166718511845,0.0302701812617227,-0.0744962737848215,0.0441628367611315,0.616346398760183
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),16133,-0.0748108289596227,0.0586510699568868,-0.189766926075121,0.0401452681558754,0.202142327621561
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),16133,-0.0263722204732724,0.0300921514747548,-0.0853528373637918,0.032608396417247,0.380835449952208
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),16133,-0.0781361574168609,0.0880329365599364,-0.250680713074336,0.0944083982406145,0.374780670589503
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),16133,-0.102323779756289,0.0563302944201385,-0.21273115681976,0.0080835973071826,0.0693128175342158
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),16133,-0.0175803273750441,0.060802634300667,-0.136753490604351,0.101592835854263,0.772479804367961
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),16133,-0.0590898707911586,0.0676389490477438,-0.191662210924737,0.0734824693424193,0.382345235203734
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),16133,0.10545557611456,0.0784317841825402,-0.0482707208832187,0.259181873112339,0.178789022012462
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),16133,-0.0191528567307782,0.0586385249378858,-0.134084365609034,0.095778652147478,0.74395514732351
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,16133,-0.0310329726828257,0.0296716380022207,-0.0891893831671782,0.0271234378015269,0.295632123691238
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,16133,-0.0390578106061484,0.0463422387871709,-0.129888598629003,0.0517729774167066,0.399345912226994
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,16133,0.0261418343863031,0.0718490835282103,-0.114682369328989,0.166966038101595,0.715979520873172
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,16133,0.095927389274661,0.0937324835467161,-0.0877882784769025,0.279643057026224,0.306126223879427
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,16133,0.0157307120701162,0.0579348222255497,-0.0978215394919612,0.129282963632194,0.785991289700616
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,16133,0.0725773976174829,0.0945701598842365,-0.112780115755621,0.257934910990586,0.44282821515237
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,16133,0.0501737585137043,0.091338662291242,-0.12885001957713,0.229197536604539,0.582796444732746
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,16133,-0.103050218861163,0.0499319554496742,-0.200916851542524,-0.00518358617980137,0.0390514181500014
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,16133,0.0647750432773174,0.0481656737575246,-0.0296296772874307,0.159179763842066,0.178696377583637
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,16133,-0.0842709504988918,0.0688786873603734,-0.219273177725224,0.05073127672744,0.221170426250155
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,17247,0.0184151550285908,0.0174790075286047,-0.0158436997274743,0.052674009784656,0.292099921237954
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,17267,0.0280514556452274,0.0181691209650129,-0.00756002144619783,0.0636629327366526,0.122628905420164
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29060.Recent worrying too much about different things,17256,0.0315477172688725,0.0167017620630687,-0.00118773637474204,0.0642831709124871,0.058923933331189
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29061.Recent trouble relaxing,17259,0.0188406353333278,0.0176509360085365,-0.0157551992434037,0.0534364699100594,0.285805521402392
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29062.Recent restlessness,17279,0.0294643240015472,0.02513766415412,-0.019805497740528,0.0787341457436224,0.241165614041951
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,17232,0.0144454649193015,0.0179305421008677,-0.0206983975983993,0.0495893274370022,0.420464702316193
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29064.Recent feelings of foreboding,17225,0.00791583004194229,0.0204657385418268,-0.0321970175000382,0.0480286775839228,0.698920550261932
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,16133,-0.0238301506264038,0.0317716623130807,-0.086102608760042,0.0384423075072345,0.453239039707123
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,16133,-0.109421631343119,0.0535440383396666,-0.214367946488866,-0.00447531619737288,0.0410110840693951
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',16133,-0.128276452180739,0.0686153799834605,-0.262762596948322,0.0062096925868437,0.0615714013483458
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,16133,-0.088511114723338,0.0727779058190262,-0.231155810128629,0.0541335806819533,0.223933744878968
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,16133,-0.000280561865977064,0.0480583277071292,-0.0944748841719502,0.0939137604399961,0.995342092653272
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,16133,-0.0336445678144247,0.0515432726986749,-0.134669382303828,0.0673802466749782,0.513930567433797
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,16133,-0.0278785646716674,0.0517339403889856,-0.129277087834079,0.0735199584907444,0.589974714414284
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,16133,-0.013426504715069,0.0479558226559885,-0.107419917120807,0.0805669076906685,0.77949910574915
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,16133,-0.102571193032652,0.0633724262486686,-0.226781148480042,0.0216387624147385,0.105564526215882
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29076.Felt loved as a child,17197,0.00327527453296923,0.0155515715583549,-0.0272058057214064,0.0337563547873448,0.833196211401049
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29077.Physically abused by family as a child,17221,-0.0219893767413364,0.0208162072273473,-0.0627891429069371,0.0188103894242642,0.290819307075869
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29078.Felt hated by family member as a child,17192,0.0212858883532594,0.0211568884141911,-0.0201816129385552,0.0627533896450739,0.314382940360456
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29079.Sexually molested as a child,17067,0.0194240328355129,0.0283882902172997,-0.0362170159903945,0.0750650816614202,0.493841175303345
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,17165,-0.0160309545606981,0.022690960949563,-0.0605052380218416,0.0284433289004454,0.479892587191078
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,17198,0.0155375377829504,0.029201345948575,-0.0416971002762565,0.0727721758421573,0.594675437112996
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,17091,0.0259237908528604,0.0228660530703465,-0.0188936731650188,0.0707412548707396,0.256926297446215
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,17213,0.00824413180728104,0.0256504677140043,-0.0420307849121674,0.0585190485267295,0.747909077271573
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,17161,0.0540706756650328,0.0360747084518787,-0.0166357529006495,0.124777104230715,0.133930248906054
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,17161,0.0119205822918972,0.0345923578351959,-0.0558804390650869,0.0797216036488813,0.730398119801601
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,17213,-0.0338486199476227,0.0289200666583856,-0.0905319505980584,0.022834710702813,0.241848271184382
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,17215,-0.0188492706553657,0.0182150852895878,-0.0545508378229577,0.0168522965122264,0.300769168341763
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,17223,-0.0122244190184856,0.0169976392909803,-0.0455397920288071,0.0210909539918358,0.4720377282986
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,17241,-0.0230786559948829,0.0231281084417789,-0.0684097485407695,0.0222524365510036,0.31836039273217
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,17218,-0.0162090855404714,0.021261679419679,-0.0578819772030422,0.0254638061220994,0.445854737771024
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,17226,-0.0393096877886392,0.0140113067053981,-0.0667718489312195,-0.0118475266460589,0.00502841936458086
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15356,-0.0263077403020591,0.0161295082178184,-0.0579215764089831,0.00530609580486501,0.102904146361395
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15394,-0.0373641447855301,0.0162803876242546,-0.0692737045290691,-0.00545458504199116,0.0217442195698771
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29104.Ever used cannabis,17213,-0.0322200144191351,0.020127465549173,-0.0716698468955141,0.00722981805724393,0.109439950051788
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29108.Ever thought that life not worth living,17132,0.0167137958589425,0.0177300294772474,-0.0180370619164623,0.0514646536343474,0.345856419571309
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29109.Ever contemplated self-harm,17175,0.023000282751315,0.0238921947354332,-0.0238284189301342,0.0698289844327641,0.335727065028629
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29111.Ever self-harmed,17201,0.0221090183762388,0.0384449507320729,-0.053243085058624,0.0974611218111017,0.565243031209541
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,17197,-0.0149591439592166,0.0254693757370935,-0.0648791204039198,0.0349608324854865,0.556984132646056
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17441,0.0568566475721425,0.0675853858671734,-0.0756107087275175,0.189324003871802,0.400215777389249
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17441,0.00284790583314724,0.0520719881851807,-0.0992131910098069,0.104909002676101,0.956384704607037
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17441,0.0881595087994822,0.0557676695267121,-0.0211451234728735,0.197464141071838,0.113933815307802
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17441,0.0057276523970745,0.0759210157982466,-0.143077538567489,0.154532843361638,0.939863708792941
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,17180,-0.0333573982342415,0.0158813094300242,-0.0644847647170889,-0.00223003175139414,0.0357065825664138
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X29153.Pain or discomfort today,17206,0.00956861924756697,0.014974001075933,-0.0197804228612618,0.0389176613563957,0.52282134323981
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29154.Anxiety or depression today,17206,0.0104599435084372,0.0187356790923642,-0.0262619875125965,0.0471818745294709,0.576653599277721
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,16783,0.0139929451634968,0.0146356858721835,-0.0146929991459829,0.0426788894729764,0.339043581087844
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,17152,0.017639455453197,0.0159288166559841,-0.0135810251925318,0.0488599360989258,0.268139718264063
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,17152,-0.0222791349945191,0.0159829871503492,-0.0536057898092036,0.00904751982016537,0.163357388966259
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,17152,0.00477606694661394,0.0199331890360553,-0.0342929835640544,0.0438451174572823,0.810640318734408
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,17152,0.0211923036437971,0.0215186620860269,-0.0209842740448155,0.0633688813324098,0.324719666281731
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,17152,-0.0513837015450827,0.0347157998263653,-0.119426669204759,0.0166592661145933,0.138858439335343
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,17152,-0.014197179903546,0.0164462086429425,-0.0464317488437132,0.0180373890366213,0.388012433118707
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,17149,-0.00197847463857211,0.0179044348274447,-0.0370711669003638,0.0331142176232196,0.912012611936763
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,17149,-0.0118675671639413,0.0261688131946701,-0.0631584410254946,0.0394233066976121,0.650194200755161
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,17149,0.0100583870238187,0.0405200310876238,-0.0693608739079239,0.0894776479555612,0.803957526847087
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,17149,0.0809205024643796,0.0363130264151609,0.00974697069066426,0.152094034238095,0.0258657592987157
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,17149,0.00220453429818051,0.0535224884331423,-0.102699543030778,0.107108611627139,0.967145754652463
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,17149,-0.00938207412996887,0.0257383100434749,-0.0598291618151796,0.0410650135552419,0.715475825157914
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,16864,0.0259502496142156,0.0181911459508888,-0.00970439644952635,0.0616048956779576,0.153733400452221
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,17081,0.012681690785066,0.0166234430640116,-0.0199002576203967,0.0452636391905286,0.445545561688399
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29173.Frequency of feeling left out,16992,0.00869961473672953,0.0172454072857529,-0.0251013835433463,0.0425006130168053,0.613944850586921
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,17062,0.011268548219189,0.0178188026078813,-0.0236563048922585,0.0461934013306364,0.527136308799279
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,17184,0.0151489420963033,0.0146653726125823,-0.013595188224358,0.0438930724169646,0.301630825718397
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29176.Ability to make it through stressful events,17184,-0.0124037742884209,0.0142702026142041,-0.0403733714122608,0.0155658228354191,0.38474552400834
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29177.Quick recovery from stressful events,17184,0.0117801257753151,0.014554298319404,-0.0167462989307168,0.040306550481347,0.418301190873486
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,17184,-0.0153310092307549,0.014371049261684,-0.0434982657836556,0.0128362473221457,0.2860779817427
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,17184,0.00839897862140964,0.0145679211876909,-0.0201541469064645,0.0369521041492838,0.564258294596038
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,17184,-0.00951841122073312,0.0144263151682013,-0.0377939889504078,0.0187571665089415,0.509394216898105
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29181.General happiness,17085,0.0104129872183592,0.0149979589719315,-0.0189830123666265,0.0398089868033449,0.487507541951393
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29182.Belief that own life is meaningful,16895,-0.000871515381351279,0.0149723207871124,-0.0302172641240915,0.0284742333613889,0.953583289981779
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11498,0.0280174378677867,0.017648472514586,-0.00657356826080178,0.0626084439963752,0.112420725432832
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2946.Father's age,11278,-0.00102487889694041,0.0141957363670316,-0.0288485221763224,0.0267987643824416,0.942447013210986
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,12880,0.0134093677673494,0.010791079056211,-0.00774114718282411,0.034559882717523,0.214025175542563
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50032,0.0945018218935758,0.00461793259107531,0.0854506740150682,0.103552969772083,1.08027834304991e-92
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50032,0.0134543912252042,0.00517141528706003,0.00331841726256654,0.0235903651878418,0.00927944646176401
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,50032,-0.0298146299550718,0.0055319975408416,-0.0406573451351214,-0.0189719147750223,7.09778160643154e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,50032,-0.00564583032912002,0.00540621104427262,-0.0162420039758944,0.00495034331765432,0.29634103989561
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,50032,-0.0258733673032053,0.00457082932338957,-0.0348321927770489,-0.0169145418293617,1.51720384463202e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50031,-0.0485781922048766,0.0045802485488709,-0.0575554793606635,-0.0396009050490896,2.97955704216662e-26
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50031,-0.0534152332317054,0.004469249248058,-0.0621749617578991,-0.0446555047055118,7.0506570827706e-33
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50032,0.0296105854419331,0.00446923870987891,0.0208508775705705,0.0383702933132958,3.49762075496092e-11
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30080.Platelet count,50032,0.354938211266946,0.00429029369321857,0.346529235628238,0.363347186905654,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30090.Platelet crit,50032,0.319637787223098,0.0044509951315364,0.310913836765286,0.328361737680909,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50032,-0.16106930930051,0.00433334746987048,-0.169562670341456,-0.152575948259564,2.50007269431227e-298
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,50032,-0.0998629500662547,0.00442173439813278,-0.108529549486595,-0.0911963506459144,2.24761179457918e-112
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,49959,0.0509194027847185,0.00456190668552088,0.0419780656810976,0.0598607398883394,6.77984438054339e-29
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30130.Monocyte count,49959,0.0490342135287786,0.0045982431334049,0.040021656987305,0.0580467700702522,1.60744544536066e-26
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30140.Neutrophill count,49959,0.0818011255934499,0.00457031432608568,0.072843309514322,0.0907589416725779,2.03198974642947e-71
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30150.Eosinophill count,49959,0.0472876620174357,0.00445509556280966,0.0385556747143288,0.0560196493205427,2.72795473483532e-26
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30160.Basophill count,49959,0.113965406963959,0.00928706547434631,0.0957627586342401,0.132168055293678,1.44672462346032e-34
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,49959,-0.0895106219442969,0.0438506313301568,-0.175457859351404,-0.00356338453718946,0.0412300490767892
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,49959,-0.0263243183025774,0.00449235541638979,-0.0351293349187013,-0.0175193016864534,4.66316362331347e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,49959,-0.0168037713448366,0.00455001044526994,-0.0257217918175657,-0.00788575087210753,0.000221748291286462
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,49959,0.0229640501348261,0.00444679268061222,0.0142483364808261,0.031679763788826,2.42416360318611e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,49959,0.0178723525591741,0.00441445445022974,0.00922002183672381,0.0265246832816244,5.16029218856246e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30220.Basophill percentage,49959,-0.00779976755930224,0.00439467232326808,-0.0164133253129077,0.000813790194303199,0.0759331300898586
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,49958,-0.0905009288843811,0.0438880656548385,-0.176521537567865,-0.0044803202008976,0.0392047896278007
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,49157,0.0393016968470931,0.0047358713783507,0.0300193889455257,0.0485840047486604,1.07876727079249e-16
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,49157,0.0418026103265804,0.00483833584869492,0.0323194720631383,0.0512857485900224,5.79353183920229e-18
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,49157,-0.0166840055192779,0.00451191625198742,-0.0255273613731732,-0.00784064966538258,0.000217742730630042
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,49157,-0.00495049095942783,0.00454877273910097,-0.0138660855280657,0.00396510360921007,0.276462052622423
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,49157,0.0119848519446093,0.00473423484081462,0.00270575165661261,0.0212639522326059,0.0113597382938534
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,49157,0.0335735540036154,0.0048378320211222,0.0240914032422159,0.0430557047650149,3.975248628359e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,49157,0.0355381159325711,0.00491266888531377,0.0259092849173562,0.0451669469477861,4.7589045149627e-13
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,16273,0.0158095470946306,0.007898363838662,0.000328753970853034,0.0312903402184081,0.0453418733586942
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50135,-0.00682901661406208,0.00479659555423954,-0.0162303439003716,0.00257231067224743,0.154533308461134
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30520.Potassium in urine,50033,-0.0058260068528978,0.00446839294257499,-0.0145840570203448,0.00293204331454917,0.192298919311348
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30530.Sodium in urine,50018,-0.0108468274985875,0.00467021341564354,-0.0200004457932488,-0.00169320920392615,0.0202070637464559
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30600.Albumin,45099,0.0455833568658554,0.00479935827483677,0.0361766146471753,0.0549900990845354,2.24470239834896e-21
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,49204,0.0606426382249504,0.0045932550855505,0.0516398582572714,0.0696454181926294,9.91272253591853e-40
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,49197,0.0283558854070058,0.00486299908389878,0.0188244072025642,0.0378873636114474,5.54575796412892e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,44817,-0.00373547064820051,0.00527561724720171,-0.0140756804527159,0.00660473915631485,0.478909668927008
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,48936,0.0777478028873287,0.00443966443561681,0.0690460605935197,0.0864495451811376,1.87563391586809e-68
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,49055,0.00654407269835034,0.00461983438969887,-0.00251080270545944,0.0155989481021601,0.156630621454696
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,41763,-0.0428575906198811,0.00497796400027638,-0.0526144000604228,-0.0331007811793394,7.59235474356232e-18
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30670.Urea,49182,-0.014926832462153,0.00470215975339968,-0.0241430655788164,-0.00571059934548966,0.00150206493039488
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30680.Calcium,45097,0.0874141770042407,0.00464249683326371,0.0783148832110438,0.0965134707974375,8.75353210727123e-79
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30690.Cholesterol,49215,0.0756370289030467,0.00450726902664301,0.0668027816108264,0.084471276195267,5.02559139943912e-63
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30700.Creatinine,49196,-0.0409302472168247,0.00545640174026774,-0.0516247946277495,-0.0302356998059,6.42362093286976e-14
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30710.C-reactive protein,49065,0.0959877573086205,0.00496983398156522,0.0862468827047526,0.105728631912488,8.31385856958679e-83
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30720.Cystatin C,49216,0.0251805376959585,0.00521775081538447,0.014953746097805,0.0354073292941121,1.39763416470881e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,49194,0.0724341909478806,0.00494926815419595,0.0627336253656565,0.0821347565301046,2.11372951563147e-48
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30740.Glucose,45044,0.0271964809604116,0.00479200669239143,0.0178041478433244,0.0365888140774988,1.39225522842827e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),48932,0.0343858581064833,0.00484021570982976,0.0248990353152169,0.0438726808977496,1.2266922965055e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,45069,-0.0269807706626935,0.0054967586831525,-0.0377544176816724,-0.0162071236437146,9.21017624008796e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30770.IGF-1,48960,-0.00618351659747157,0.00465926463020508,-0.0153156752726735,0.00294864207773038,0.184467136861627
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30780.LDL direct,49106,0.0739658105513242,0.00444705397156638,0.065249584767054,0.0826820363355943,5.98882880429867e-62
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,39320,-0.00285587803879931,0.0049789735096675,-0.0126146661177476,0.00690291004014899,0.566250108634503
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30810.Phosphate,44995,0.0521793036640686,0.00482541739980755,0.0427214855604458,0.0616371217676914,3.21195930607662e-27
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30830.SHBG,44677,-0.0609124995517393,0.00554982306526348,-0.0717901527596557,-0.0500348463438229,5.43892987166771e-28
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30840.Total bilirubin,49023,-0.0622102191871697,0.0047230371264103,-0.0714673719549339,-0.0529530664194055,1.49176678696153e-39
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30850.Testosterone,44450,-0.0172659703583664,0.00775785286422134,-0.0324713619722403,-0.00206057874449261,0.0260451799169376
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30860.Total protein,45062,0.132385425987881,0.00468646762357191,0.12319994944568,0.141570902530082,4.93218067148397e-174
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30870.Triglycerides,49177,0.112712758621752,0.00482592890945637,0.103253937959217,0.122171579284286,5.45117518769542e-120
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30880.Urate,49144,0.0383298547221314,0.00557401705435753,0.0274047812955906,0.0492549281486721,6.20621111203875e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30890.Vitamin D,46972,-0.0224705504389329,0.00503182863636335,-0.0323329345662051,-0.0126081663116608,7.99996020738077e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3137.Number of measurements made,46764,-0.00865357088005923,0.0107329177023151,-0.0296900895765969,0.0123829478164784,0.420094437339448
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3143.Ankle spacing width,29265,-0.0212202266934647,0.00810885777550666,-0.0371135879334577,-0.0053268654534716,0.00887729384204637
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",29263,-0.0127588091565542,0.00624546832380351,-0.0249999270712091,-0.000517691241899338,0.0410722036497458
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3146.Speed of sound through heel,29265,-0.0218866520936514,0.00603115032453251,-0.0337077067297352,-0.0100655974575677,0.000285077637762987
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",29265,-0.0194337411924324,0.00609449627331077,-0.0313789538881215,-0.00748852849674329,0.00143046679844158
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),29244,-0.0185552392264101,0.00610202320302385,-0.0305152047043369,-0.00659527374848336,0.00236132767169969
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3526.Mother's age at death,30773,-2.920398e-05,0.005848314,-0.0114919,0.01143349,0.9960158
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),15935,0.00178021096665021,0.0079072484353701,-0.0137179959666752,0.0172784178999756,0.821875904415399
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",10172,-0.0098138799436292,0.0103130080786254,-0.0300273757777349,0.0103996158904765,0.341321467225467
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4100.Ankle spacing width (left),16587,-0.0177585242637997,0.0103190021202004,-0.0379837684193925,0.00246671989179315,0.0852779007829529
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16583,-0.0179358839682359,0.00794030963934773,-0.0334988908613575,-0.00237287707511437,0.0239063220767284
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),16587,-0.0157613422120031,0.00767926846319644,-0.0308127083998682,-0.00070997602413812,0.0401412700222891
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16587,-0.0174461195472406,0.00775948456142621,-0.032654709287636,-0.00223752980684525,0.0245662895139621
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),16574,-0.0163582854273376,0.00776977498247639,-0.0315870443929913,-0.00112952646168387,0.0352737487392975
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16587,-0.0174628582180375,0.00775950226756146,-0.0326714826624579,-0.00225423377361702,0.0244294754463106
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4119.Ankle spacing width (right),16577,0.00104558284813757,0.0101467143163972,-0.0188419772120009,0.020933142908276,0.917927356144769
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16576,-0.0134232541490513,0.00797270803833214,-0.0290497619041823,0.00220325360607965,0.0922680716519768
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),16577,-0.0127889263648106,0.00768803833848056,-0.0278574815082325,0.00227962877861129,0.0962345720878717
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16577,-0.0135170653314483,0.0077768149011488,-0.0287596225377,0.00172549187480332,0.0822076257097788
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),16563,-0.0122423357720099,0.00778389838310093,-0.0274987766028877,0.0030141050588679,0.115789596940437
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16577,-0.0135171463146389,0.00777682923366221,-0.0287597316126168,0.00172543898333904,0.0822063555074335
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4194.Pulse rate,17235,0.0497556740669171,0.0073751724602184,0.0353003360448891,0.0642110120889452,1.56409061537038e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4195.Pulse wave reflection index,17235,-0.0247257635605057,0.00756586567129969,-0.0395548602762531,-0.00989666684475836,0.00108496484234012
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,17225,-0.0146312221237024,0.00752800777010474,-0.0293861173531077,0.000123673105702894,0.0519634115600436
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,17235,0.0103715224142784,0.00760091471895998,-0.00452627043488312,0.02526931526344,0.172425010174213
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4199.Position of pulse wave notch,17235,0.0304113860590001,0.00737015988325631,0.0159658726878178,0.0448568994301825,3.70402173247255e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,17235,0.0173606774441217,0.00764066060356302,0.00238498266113823,0.0323363722271053,0.023090118105937
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),16912,-0.0543040829126745,0.0469499634944886,-0.146326011361872,0.0377178455365233,0.247436906777313
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4270.Volume level set by participant (left),16733,-0.0180699402733121,0.0149020669603712,-0.0472779915156397,0.0111381109690155,0.225307783404873
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),16916,-0.0776379347711043,0.0456619974428191,-0.16713544975903,0.0118595802168211,0.089097695970564
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4277.Volume level set by participant (right),16719,-0.00661896549261962,0.0148168145307006,-0.0356599219727928,0.0224219909875535,0.655083123838911
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4288.Time to answer,17272,0.0299423513401838,0.00851471953463118,0.0132535010523067,0.0466312016280609,0.000438333173236072
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4290.Duration screen displayed,17272,0.00655706950502965,0.00776808748878314,-0.0086683819729853,0.0217825209830446,0.398623296203167
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X46.Hand grip strength (left),51461,-0.0173991277623746,0.00630235072531348,-0.029751735183989,-0.00504652034076019,0.00576916637941671
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X47.Hand grip strength (right),51465,-0.0132052418237684,0.00625131553441278,-0.0254578202712175,-0.000952663376319374,0.0346574686186639
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X48.Waist circumference,51608,0.07766123,0.009715923,0.05861802,0.09670444,1.341969e-15
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X4803.Tinnitus,16959,-0.000891374561866665,0.0176167918509868,-0.0354202865898008,0.0336375374660674,0.959646447260011
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4825.Noisy workplace,17176,0.0414379355020902,0.0197559988177078,0.00271617781938287,0.0801596931847975,0.0359651463320798
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,17068,0.0223199179296834,0.0250802499470234,-0.0268373719664824,0.0714772078258492,0.373510652978633
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X49.Hip circumference,51599,-0.0282635671458614,0.00778725996728767,-0.0435265966817453,-0.0130005376099776,0.000284286468160804
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X50.Standing height,51555,-0.0351507991289881,0.00618978201219426,-0.0472827718728889,-0.0230188263850874,1.36336659203681e-08
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X5057.Number of older siblings,15160,0.0155997967764177,0.0158788537120798,-0.0155227564992587,0.046722350052094,0.325905776884837
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X51.Seated height,51321,-0.0313531544308182,0.00575495010095156,-0.0426328566286832,-0.0200734522329531,5.11636967098525e-08
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5181.Ever had eye surgery,11635,0.00913050393977368,0.0365346544365489,-0.0624774187558621,0.0807384266354094,0.802658648898915
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),11605,0.0162283184948821,0.00895033791335264,-0.0013143438152891,0.0337709808050532,0.0698343139252896
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),11604,0.0274153334581058,0.00902792332976885,0.00972060373175884,0.0451100631844527,0.00239693917647981
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),11475,0.0212673016307651,0.00908767960827443,0.00345544959854725,0.039079153662983,0.0192886976687417
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),11473,0.0257449203777403,0.00913328568308791,0.00784368043888796,0.0436461603165926,0.0048285945711262
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",11564,0.0390381229981291,0.0189241242076044,0.00194683955122443,0.0761294064450338,0.0391467080980008
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),11564,-0.0575423602166114,0.130214829557353,-0.312763426149023,0.1976787057158,0.658567472268166
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5201.logMAR, final (right)",11452,0.0125466524663111,0.00909731153857034,-0.00528407814928681,0.0303773830819089,0.167872248485843
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5202.Number of rounds to result (right),11564,0.0241912833413653,0.0177773092837215,-0.0106522428547288,0.0590348095374595,0.173604885850295
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",11558,0.0377427558179738,0.0188528672869346,0.000791135935581888,0.0746943757003656,0.0453119921710356
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),11558,-0.0174986109055807,0.117711490102973,-0.248213131507408,0.213215909696246,0.881827064990033
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5208.logMAR, final (left)",11449,0.0061342288377651,0.00910054753249142,-0.0117028443259181,0.0239713020014483,0.500292817613861
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5209.Number of rounds to result (left),11553,0.0551605546401335,0.017839064990175,0.0201959872593904,0.0901251220208765,0.00199206007690913
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",11054,0.0106205073439486,0.0090221951093035,-0.00706299507028625,0.0283040097581834,0.239159675446833
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",11054,0.0249880167419897,0.00897363321523661,0.00739969564012597,0.0425763378438535,0.00536843607828323
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),11054,0.0200288786147623,0.00909953426095753,0.00219379146328559,0.0378639657662391,0.0277503935129779
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),11054,0.029359446740772,0.00904200629148428,0.0116371144094628,0.0470817790720812,0.00116974117168828
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",11025,0.0194167210827249,0.00905693676562525,0.00166512502209943,0.0371683171433504,0.0320666780965426
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",11025,0.0222056215060299,0.00898479660433871,0.00459542016152601,0.0398158228505338,0.0134710391563744
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),11025,0.0044127425752819,0.00914258882585218,-0.0135067315233884,0.0223322166739522,0.629348267092793
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),11025,0.0156208511190529,0.00905464869408818,-0.00212626032135991,0.0333679625594658,0.084524047561747
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11550,0.0620552473298263,0.0807581903269909,-0.0962308057110759,0.220341300370728,0.442260502400876
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51445,-0.0172885022977981,0.0251430668437958,-0.0665689133116378,0.0319919087160416,0.491704563755446
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51445,-0.0637365499796385,0.0272866031068494,-0.117218292069063,-0.0102548078902137,0.0195045296779645
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51445,-0.0626708232910553,0.0261070269017518,-0.113840596018489,-0.0115010505636218,0.0163746696232017
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51445,-0.0434001361687891,0.0111929812734776,-0.0653383794648051,-0.021461892872773,0.000105691602312591
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51445,0.0392499029880712,0.0102950037653424,0.019071695608,0.0594281103681423,0.000137717698558885
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",23244,-0.00604846175212888,0.0129887325105357,-0.0315063774727789,0.0194094539685212,0.641456167444636
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",23244,0.0093360140405295,0.0352584039994189,-0.0597704577983316,0.0784424858793906,0.791174873915201
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",23244,-0.012280053175734,0.0251988785780759,-0.0616698551887627,0.0371097488372947,0.626032360395045
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",23244,0.0316407961523946,0.015365507840478,0.00152440078505773,0.0617571915197315,0.0394853162117583
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51603,0.0388140196408889,0.0172321341507151,0.00503903670548721,0.0725890025762906,0.024299869691296
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51603,-0.0144800831744491,0.0221886846760307,-0.0579699051394692,0.029009738790571,0.514024430008804
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51603,0.0106292236537103,0.0170286679552104,-0.022746965538502,0.0440054128459227,0.532501740422894
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51603,-0.0285615594610163,0.0279892617077907,-0.0834205124082861,0.0262973934862534,0.307521275996025
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51603,0.0960573488826438,0.0682675356116797,-0.0377470209162484,0.229861718681536,0.159412016434117
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51603,0.101703523913372,0.046878658309022,0.00982135362768879,0.193585694199055,0.0300488500609961
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51603,0.210245993223944,0.0741702895084721,0.0648722257873382,0.355619760660549,0.00458953220680477
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51444,0.00330885002913717,0.0142830121013223,-0.0246858536894545,0.0313035537477288,0.816800443013762
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51444,0.0273604483784676,0.0244056692828313,-0.0204746634158817,0.0751955601728169,0.262263568374521
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51444,0.014734304764181,0.0128222749581288,-0.0103973541537514,0.0398659636821134,0.250512741541853
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51444,0.042096502008008,0.0215077085115732,-5.86066746754085e-05,0.0842516106906914,0.0503205361203642
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51444,0.0260201131078764,0.0213338000093173,-0.0157941349103856,0.0678343611261383,0.222597062691229
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51444,0.0142993664537952,0.0119867129772341,-0.00919459098158355,0.037793323889174,0.232900431650849
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,16001,-0.12793736970965,0.0283063707672878,-0.183417856413534,-0.0724568830057657,6.23604389712358e-06
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,16001,-0.0783110997566683,0.0243044927057179,-0.125947905459875,-0.0306742940534611,0.00127517013090607
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,16001,0.01815828156592,0.0336290524644219,-0.047754661264347,0.084071224396187,0.58923340242143
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,16001,0.0921271380503989,0.0267484285262438,0.039700218138961,0.144554057961837,0.000574204750049219
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51393,0.00362994301440026,0.0362485390242953,-0.0674171934732186,0.0746770795020191,0.920233256673012
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51393,0.0550432869661139,0.0540336559253508,-0.0508626786475736,0.160949252579802,0.308357225652307
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51393,-0.0622750163168775,0.0950084326750952,-0.248491544360064,0.123941511726309,0.512169221308917
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51393,-0.0668868913094648,0.0936634857427737,-0.250467323365301,0.116693540746372,0.475156733042174
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51393,0.00303086564554565,0.0316144899332087,-0.0589335346235434,0.0649952659146347,0.923624584735642
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51393,0.124744691779723,0.042079515963483,0.0422688404912967,0.20722054306815,0.00303315164541843
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51393,0.0265777270151301,0.0194774027909882,-0.0115979824552068,0.064753436485467,0.172403136436506
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16667,0.0351470399308121,0.0312176538405711,-0.0260395615967072,0.0963336414583314,0.260236502907433
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16667,0.0164258491291983,0.0335406211343807,-0.049313768294188,0.0821654665525845,0.624331405481284
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16667,-0.0291280848551632,0.0454457413346402,-0.118201737871058,0.0599455681607316,0.521569179311148
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16667,0.060799915208214,0.0160436069412336,0.0293544456033961,0.0922453848130319,0.000151381182459484
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",23420,-0.0383962177197119,0.0148666580972196,-0.0675348675902623,-0.00925756784916146,0.00980887399797997
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",23420,0.0118605624447491,0.0144845390358717,-0.0165291340655593,0.0402502589550576,0.412884368473192
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",23420,0.0344123456047035,0.0132465416133349,0.00844912404256711,0.0603755671668398,0.00938719736931296
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",23421,0.0503846329778236,0.031492773054493,-0.0113412022089827,0.11211046816463,0.109638877638768
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",23421,0.0107062311685184,0.0188046901533865,-0.0261509615321192,0.047563423869156,0.569132012588112
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",23421,-0.0404112308656944,0.0253011913836828,-0.0900015659777127,0.00917910424632391,0.110233151985957
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51444,-0.00822042695755115,0.0300851273028887,-0.067187276471213,0.0507464225561107,0.784670679925561
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51444,0.0111978264972058,0.021045730714152,-0.0300518057025321,0.0524474586969437,0.594679004707111
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51444,-0.0481118511516372,0.0578250401419839,-0.161448929829926,0.0652252275266513,0.405398968630485
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51444,-0.00713232707247065,0.0216207404844032,-0.0495089784219009,0.0352443242769596,0.741489281487542
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51444,0.0183273350986208,0.0246599219954545,-0.0300061120124701,0.0666607822097117,0.457362008094209
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51444,-0.0128087314994892,0.0283416042772878,-0.0683582758829733,0.0427408128839949,0.651313430369597
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51444,-0.0252358603095109,0.00931396555708479,-0.0434912328013971,-0.00698048781762471,0.00674142084090217
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,10036,-0.0385075700353448,0.0269488589358254,-0.0913273335495627,0.014312193478873,0.153060458082295
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,10036,-0.00208034338513254,0.033485514644321,-0.0677119520880018,0.0635512653177367,0.95046320048143
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,10036,-0.0135717314369599,0.0238279007342843,-0.0602744168761571,0.0331309540022372,0.568980039146711
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,10036,0.0125553801537469,0.0213053807718699,-0.0292031661591181,0.0543139264666119,0.555669573665087
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51681,0.0354497947955237,0.0109111872487857,0.0140638677879037,0.0568357218031437,0.00115909818133712
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51681,0.0742073100834447,0.0312890448229952,0.0128807822303741,0.135533837936515,0.0177115093877024
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51681,0.00275718954430132,0.0101988320305772,-0.01723252123563,0.0227469003242327,0.786896961948348
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51681,-0.00693212142393738,0.00986470677687299,-0.0262669467066084,0.0124027038587337,0.482233763557113
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51681,0.0310120628220783,0.0152544787389239,0.00111328449378749,0.0609108411503692,0.0420595615436825
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51681,-0.00351222071386478,0.0136163291711181,-0.0302002258892562,0.0231757844615267,0.796452837079857
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51681,-0.00186156585698894,0.0106098272321662,-0.0226568272320346,0.0189336955180568,0.860721435717093
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51681,0.0825692877834125,0.031118387567588,0.02157724815094,0.143561327415885,0.007971158832893
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,35782,-0.0250221792338455,0.0107291303566234,-0.0460512747328274,-0.0039930837348637,0.019697155271652
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,35782,0.0105693524012836,0.0112012254901237,-0.0113850495593588,0.032523754361926,0.345386123523659
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,35782,0.0117916448757041,0.0126323860983333,-0.0129678318770292,0.0365511216284374,0.350596260850745
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,35783,-0.0222531513417726,0.0172918927963045,-0.0561452612225294,0.0116389585389842,0.19813314915844
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,35783,0.00151670350461899,0.0113348926111933,-0.0206996860133199,0.0237330930225579,0.893554861195393
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51202,-0.00373840423141187,0.0109936875441545,-0.0252860318179546,0.0178092233551309,0.733820216257864
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51202,0.00782553008587945,0.00875087518967468,-0.00932618528588292,0.0249772454576418,0.37118868561026
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51202,0.00354112464560924,0.00970984391116624,-0.0154901694202766,0.0225724187114951,0.71534112686696
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51202,0.00267659602587882,0.0175517710477092,-0.0317248752276313,0.0370780672793889,0.878795395864531
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51237,0.00280655785402009,0.00966332205784247,-0.0161335533793512,0.0217466690873913,0.771485366055049
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51237,-0.0146351323135363,0.0150766794098882,-0.0441854239569172,0.0149151593298445,0.331695680563079
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51444,0.0105645690175522,0.00951389252238975,-0.00808266032633166,0.0292117983614361,0.266816372213422
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51444,0.00317249863574261,0.0112554416460903,-0.0188881669905944,0.0252331642620797,0.778049280800192
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51444,-0.00924101334555236,0.0169852547567195,-0.0425321126687226,0.0240500859776179,0.586401909765559
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51444,0.00852916362384304,0.0215993424543792,-0.0338055475867402,0.0508638748344263,0.692932566359558
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51444,0.0225809306738422,0.0235157143438747,-0.0235098694401521,0.0686717307878366,0.336934650185597
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51444,0.0127633950302276,0.0281093899024387,-0.0423310091785522,0.0678577992390074,0.649786394628599
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",29265,-0.0194360572298714,0.00609449733382927,-0.0313812720041768,-0.00749084245556607,0.00142859096876124
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,50557,-0.0038049832317921,0.00836098244388877,-0.0201925088218141,0.0125825423582299,0.649047846707487
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X874.Duration of walks,43777,-0.00526207002919273,0.00468667279109727,-0.0144479486997434,0.00392380864135791,0.261540042193192
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,48879,0.00296205511529461,0.00809165703054089,-0.0128975926645655,0.0188217028951548,0.714319755204404
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X894.Duration of moderate activity,37861,0.00126192651318543,0.00980412032682008,-0.0179541493273819,0.0204780023537528,0.897584724290964
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,10821,0.0150406349365044,0.010033338904127,-0.00462470931558454,0.0347059791885934,0.133885779362796
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,48792,-0.00925839939831454,0.00831239845759498,-0.0255507003752007,0.00703390157857161,0.265367905051934
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X914.Duration of vigorous activity,27327,1.04177350068601e-05,0.00592284243019217,-0.0115983534281698,0.0116191888981835,0.998596608022181
